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SELF-REGULATION THEORY AND SELF-MONITORING OF BLOOD GLUCOSE 
BEHAVIOR IN TYPE 2 DIABETES MELLITUS 
Jennifer E. F. Ward 
October 1, 2014 
The present study examined self-monitoring of blood glucose (SMBG) as part of a self-
regulatory process of health decision-making using the Self-Regulation Model of illness 
perceptions, or Common Sense Model. Participants were N=185 individuals with type 2 
diabetes from a specialty diabetes clinic prescribed subcutaneous insulin or other 
injectable diabetes medication at least daily. Collected information included both medical 
chart data and self-report questionnaires completed prior receiving lab results. Self-care 
burden was generally high; the modal prescribed times per day of injecting insulin was 4 
with modal SMBG recommendations of 3-4 times per day. Participants reported high 
adherence to prescribed medication regimens, varied aherence to diet recommednations, 
and low engagement in exercise. Specific hypotheses were developed to examine the 
relationship between illness coherence and illness control beliefs (IPQ), SMBG decision-
making behavior, and outcomes including diabetes distress (PAID) and hemoglobin A1c 
level. These hypotheses were not supported. Supplemental analyses revealed that SMBG 
decision-making use was related to illness perceptions, including a positive relationship 




relationship with both outcome variables (A1c at baseline and PAID score). Both 
treatment and personal control beliefs were not associated with glucose control outcomes, 
suggesting that illness beliefs alone do not explain why some individuals are more 
successful at managing their diabetes than others. Coherence was found to differ by 
education level and SES and greatly vary in an otherwise relatively homogenous sample. 
Study findings suggest that illness perceptions play an important role in the process of 
SMBG use for decision-making as it relates to glucose control and diabetes distress. 
Results also point to possible clinical targets such as illness coherence and diabetes 
distress. The study provides a foundation for future research related to SMBG as a 
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                    INTRODUCTION    
Diabetes is a group of diseases that are characterized by defects in insulin 
production, action or both that result in impairments in blood glucose levels. An 
estimated 25.8 million people in the United States have some form of Diabetes (Centers 
for Disease Control, 2011). Complications from Diabetes include heart disease, stroke, 
kidney failure, non-traumatic lower-limb amputations, and new cases of blindness 
(Centers for Disesase Control, 2011). Of those diagnosed with diabetes, approximately 
90%-95% are classified as Type 2 Diabetes (T2DM; see appendix 1 for a guide to 
frequently-used abbreviations). T2DM is characterized by elevated circulating glucose 
levels resulting from either low production of insulin hormone or a resistance to the 
effects of insulin hormone.  
Large research trials have shown that a longer period of poor glycemic control, 
defined as a hemoglobin A1c level (A1c) above 7%, is associated with a higher risk for 
macrovascular disease (United Kingdom Prospective Diabetes Study Group, 1998), and 
that there is an increase in diabetes-related complications with poor glycemic control in 
individuals with Type 1 Diabetes Mellitus (T1DM; Diabetes Research Group, 1990). 
Poor control of glucose levels is associated with higher rates of neuropathy and foot 
problems, poor general health and well being, higher personal distress related to diabetes, 
higher incidence of psychological comorbidity, and higher depression scores (Fu, Qiu, & 
  
	   2 
Radican, 2009). Conversely, better glucose control, indicated by a lower A1c level, is 
associated with less microvascular complications of diabetes (American Diabetes 
Association, 2012). Given these results, it is imperative to learn strategies that can 
facilitate better, and faster control of blood glucose levels.  
Diabetes is a largely self-managed disease. Responsibility for the management of 
diabetes care has increasingly moved away from the medical institution and toward the 
individual (Mc Sharry, Moss-Morris, & Kendrick, 2011) as matters of lifestyle, such as 
diet and exercise, are increasingly implicated as key contributors to glucose stability. The 
primary self-management strategies for diabetes are outlined in the treatment 
recommendations from the American Diabetes Association (ADA; ADA, 2012) and the 
International Diabetes Federation (IDF; IDF, 2009) and include changes in diet, physical 
activity and the implementation of self-monitoring of blood glucose (SMBG) strategies.  
Type 2 diabetes is primarily treated with these lifestyle adjustments and, when necessary, 
oral medications and/or injectable insulin therapies.    
Self-Monitoring of Blood Glucose 
The remainder of this paper will focus primarily on the self-management strategy 
referred to as self-monitoring of blood glucose, or SMBG. Self-monitoring of blood 
glucose has long been considered a helpful strategy for those with diabetes. However, 
there has been significant debate in recent years about the appropriateness of SMBG for 
those with T2DM, particularly those with T2DM who are not treated with insulin 
therapies. Several randomized, controlled research trials have been conducted in an effort 
to discover whether or not this management strategy actually leads to improvements in 
blood glucose control (reflected by A1c) in the T2DM population (see Clar, Barnard, 
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Cummins, Royle, & Waugh, 2010 for a comprehensive systematic review). Unfortunately, 
the results have been split, with some studies finding significant improvements (Lalic et 
al., 2012) and others finding no greater improvement when compared with a control 
group (Clar et al., 2010). The differences have resulted in contention, more than one 
heated debate at scholarly conferences, and still more research aimed at identifying the 
errors of previous studies. There have been a number of meta-analyses, systematic 
literature reviews, and cost-benefit analysis attempting to find an answer to this important 
question (Clar et al., 2010).  
The Utility of Self-monitoring of Blood Glucose 
Only within the past few years has a potential consensus been proposed (Ceriello, 
2012); a 2010 conceptual review identified a link between studies supporting SMBG and 
the use of SMBG as a decision-making tool (Kolb, Kempf, Martin, Stumvoll, & Landgraf, 
2010). A large systematic review in the same year noted that, despite significant research, 
there are few studies considering the use of SMBG for feedback for decision-making 
(Clar et al., 2010). It may be that the broad shift from a medical care focus to an 
increasingly self-care focus in diabetes is mirrored in the perceived utility of SMBG in 
the coming years. As it comes to be considered a self-care, decision-making method, it is 
increasingly relevant to consider the psychological processes involved in its use. 
Current recommendations for SMBG use are important to consider. In current 
practice, there is a lack of structure in SMBG recommendations for those with T2DM 
who are not using insulin. The recommendations, if they are provided at all, may be as 
vague as ‘occasionally,’ ‘once a day,’ or ‘a few times a day.’ This can lead to an 
interesting phenomenon. In some cases, individuals my engage in perfunctory blood 
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glucose testing without any planned purpose and not use the results for any feedback, 
doing the testing simply because their health provider instructed them to do so. Or for 
those engaging in SMBG with a sense of purpose, they may choose to test if, and only if, 
they had a concern about their blood glucose level. In this situation, it is likely that the 
only feedback they are receiving from SMBG are blood glucose levels that are, indeed, 
consistently higher or lower than the desired glucose range and therefore, contribute to a 
sense of “failure.” Similarly, if one chooses to engage in SMBG daily, at the same time 
of day, they are receiving a very limited range of information. If, instead, the 
recommendations as to the purpose of SMBG are to test as a means of giving feedback to 
their healthcare provider, one may not personally attend to the results at all or might 
purposefully engage in SMBG when levels are in a normal range, thus receiving only 
‘positive’ feedback and potentially leading to an inflated sense of “success.” Interestingly, 
all of these scenarios describe an individual who is adhering to provider 
recommendations. It is easy to imagine how vague SMBG recommendations can lead to 
confusing or conflicting feedback. One reason that more structured SMBG regimens, as 
have been recommended very recently (Stephens et al., 2011), have proven to be 
successful may be because they provide more reliable feedback based on the collection of 
data at predetermined time points rather than self-selected time points. 
Complicating the issue of SMBG recommendations is that the optimal utility of 
SMBG feedback is not clearly communicated. A 2010 review identified a pattern of 
differing perceptions of the utility of SMBG feedback between patients and their 
healthcare providers (Clar et al., 2010). Patients tended to expect that the primary 
function of SMBG results were to allow providers to make decisions about their 
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treatment strategies. Conversely, healthcare providers tend to report that SMBG is 
primarily a decision making tool for patients to make behavioral changes (Clar et al., 
2010). These perceived uses offered by both groups are valid, but rather distinct. If there 
is not an agreed-upon utility for SMBG across patient/provider dyads, this self-care tool 
may have limited effectiveness.  
Self-Monitoring of Blood Glucose Literature and Theory 
The recency of the shift in perceptions of SMBG utility mean that to date, little 
attention has been given to the psychological processes involved in SMBG use. As such, 
the vast majority of prior SMBG research is lacking is a conceptual foundation for the 
mechanisms that underlie the relationship between SMBG testing and decision-making. 
Some reviews of prior literature offer a conceptual framework to explain SMBG efficacy 
(Aalto & Uutela,1997; McAndrew, Schneider, Burns, & Leventhal, 2007; Wing, Epstein, 
Nowalk, & Lamparski,1986), but there are few research studies built on a conceptual 
model. Though prior research has been helpful in providing information about overt 
patient- and provider-cognitions and -emotions surrounding this facet of diabetes self-
management, the data tends to be frequency driven and does not consider health decision-
making. The psychological, “nonconscious” processes are an important next step for 
SMBG research. In health psychology literature, these processes have been consistently 
shown to contribute to goal selection, goal pursuit and other self-care decisions and 
behaviors in many illnesses (Aarts, 2007), including diabetes (Thoolen, Ridder, Bensing, 
Gorter, & Rutten, 2008). The clearest understanding of the utility of SMBG in T2DM 
will come from research grounded in a theoretical framework, through which to explain 
psychological factors that are associated with its successful use are explained, and upon 
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which expectations for change are based. In sum, theoretically-informed research, drawn 
from broader health psychology research on underlying psychological processes that 
explain illness behaviors as they relate to self-management choices, is a critical next step 
toward a greater understanding SMBG as a self-management strategy. 
Self-Regulation Model of Illness Behavior 
Health psychology theories for health behaviors abound. When selecting a model 
of illness behavior one consideration is whether it is intervention-conducive, such that it 
enables providers to use the information to develop interventions that can lead to 
improvements in the health of their patients. In a heavily self-managed illness it is also 
important that a conceptual model characterize the individual as able to act on their own 
values and goals in determining their behavior in response to a specific situation 
(Cameron & Leventhal, 2003). This quality is important for applicability to an 
intervention because it assumes the person is an active participant in the process. Goal-
directed behavior is seen as influenced not only by a cognitive process of goal selection 
but also by affective experience, physiological experience and social input. One such type 
of health behavior model is the self-regulation model.  
Models of self-regulation view the self as critical in behavioral action, shaped by 
an ongoing process of interactions between different external and internal stimuli. As a 
result, these models capture a dynamic interplay between feedback, motivation and goal 
pursuit. The resulting feedback loops allow outcomes to serve as a reference point for 
success of efforts, which are motivated by a desire to maintain a physical status quo 
(Cameron & Leventhal, 2003). Due to the comprehensive and dynamic nature of self-
regulation theory, and the many pathways and interactions that can serve as intervention 
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points, these theories are regarded as important in the research and practice in health 
psychology (Hagger, 2010; Hagger, Wood, Stiff, & Chatzisarantis, 2010).  
The Self-Regulation Model of illness behavior (SRM; Leventhal, 1970), one of 
the first models of its kind, has been specifically adapted for chronic health conditions. 
Like other models built on self-regulation theory, the SRM views an individual as 
engaging in a continuous, moment-by-moment process of decision-making that 
incorporates an integrative system of physical, cognitive and affective information in an 
effort to maintain physical balance. This adaptation posits that people develop a 
conceptualization, or representation, of illness, against which they continually weigh 
decisions about health behavior (see figure 1). Leventhal refers to this illness 
representation as a person’s Common Sense Model (CSM; Leventhal, Leventhal, & 
Contrada,1998). A person’s CSM is developed across time through physical, social and 
cognitive input. The SRM has been studied extensively in the health population, 
including in individuals with diabetes (Grzywacz et al., 2011).  
Self-monitoring and Self-regulation  
Self-monitoring is closely related to self-regulation. The ability to self-monitor, or 
to monitor the results of previous action, allows the completion of the feedback loop of 
the SRM, which is necessary for appropriate self-regulatory action.  
Specific monitoring strategies, such as SMBG, can be understood as part of the 
self-regulatory process as well. The use of SMBG is related to a self-regulatory process 
in at least two ways. One is that the self-regulatory process may lead an individual to 
decide to engage in SMBG as a health behavior. Another is that an individual may use 
the information resulting from SMBG to make decisions about future behaviors, thus 
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using SMBG as a feedback aid. These two features are distinct but related; one is a 
resultant behavior and the other restarts the process of self-regulation. Greater self-
regulation skills have been shown to be associated with a greater frequency of 
implementing these strategies. For example, a recent study of self-management behaviors 
in those with T2DM found that participants who displayed stronger cognitive abilities, 
such as planning and problem solving, were more likely to engage in recommended self-
management strategies than those whose skills are less well-developed (Primozic, Tavcar, 
Avbelj, Dernovsek, & Oblak, 2012). Those who use SMBG in a self-regulatory manner, 
thus demonstrating a skill set, may also display more frequent engagement in SMBG 
behaviors. 
As mentioned previously, recent analyses suggest that SMBG as a personal 
decision-making tool can lead to greater metabolic control than SMBG as provider 
feedback alone. Self-regulation processes can help explain this relationship. The feedback 
loop of the SRM can be characterized as making decisions about future behaviors based 
on output, such as a number from SMBG. In a 2010 systematic review, the five most 
common themes of qualitative studies related to SMBG and related barriers included a 
failure to act on results, a lack of education for the interpretation of data and use of data, 
and patient concerns that their healthcare providers were not interested in the results of 
their testing (Clar et al., 2010). A recent study by Lalic and colleagues (2012) examined 
the use of a structured SMBG protocol in a clinical setting. In addition to metabolic 
improvements, patients were mostly positive about all aspects of the structured format 
and that more than 90% noted that, through the structured format, lifestyle adjustments 
were easier and interactions with their provider were more positive (Lalic et al., 2012). 
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Another study found greater autonomous motivation and self-efficacy ratings in those 
following a structured testing program compared with those in an active control group 
(Fisher et al., 2012). The recent trend of developing and prescribing structured testing 
protocols is in line with self-regulation theory. Testing at predetermined time points 
leaves less room for personal influence on feedback because people are not testing only 
when physiologically triggered.     
In order to link the conceptual framework of the SRM to self-monitoring behavior 
in Type 2 diabetes, each portion of the SRM is discussed below, with consideration of its 
applicability to prior research related to SMBG.   
Illness Representation or Common Sense Model  
Illness Representation. It is important to remember that every person, whether a 
patient, a researcher, or a physician, draws from a cognitive representation when thinking 
about an illness. Therefore, it is a representation that is drawn from when making health 
decisions related to an illness, when describing an illness to others and when designing 
research and interventions related to the illness. Representations are not exact. Limits in 
human capacity for perception and cognition affect the ways in which people understand 
the world around them. It is reasonable to expect that very few people understand an 
illness in the same way. People are also constrained by contextual limitations in their 
understanding of an illness including the existence of, and access to, information, social 
influence and time. In line with these limitations, some patients may actively seek health 
information and become misinformed; others may rely heavily on healthcare providers 
for information. Importantly, the healthcare providers providing this information draw 
from their own illness representations. Individuals who engage in a great deal of research 
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and study are not immune to limitations. There are epistemic, philosophical and political 
presuppositions that underlie the research that builds our understanding of medical 
phenomena (Gilman, 2011). Additionally, the biological indicators used to understand 
illness, such as A1c or blood glucose, are physiological markers of diabetes- not a direct 
measurement of the illness itself. Furthermore, as an illness becomes widespread, 
information can become even more socially relevant (Gilman, 2011) and this social 
influence can infiltrate the representation of even the most well intentioned empiricist.  
It is important to remain cognizant of the influences that shape illness 
representations. Though decision-making algorithms can be developed, SMBG is not an 
exact science. Without frequent or continuous feedback, decisions are based on discrete 
time points and may not accurately represent glucose patterns.      
Common Sense Model. The SRM, proposed by Leventhal (1970), includes as a 
major component the influence of a person’s illness representation, or CSM (see figure 1). 
The Common Sense Model provides specificity at the ‘illness representation’ level. This 
specificity allows for easy application to previous studies and may help to explain many 
areas of influence previously shown to be relevant in SMBG research.  
According to the SRM, there are several different categories of information 
people hold within their CSM of illness including identity, timeline, consequences, and 
cause. Specified categories result in a model that is more readily applied to health 
behavior research. The CSM component has been utilized in illness representation 
research with many chronic diseases including cancer, neurological disorders, 
cardiovascular disease (Heijmans & Ridder, 1998), asthma (Tettersell, 1993) and HIV 
(Rungruangsiripan, Sitthimongkol, Maneesriwongul, Talley, & Vorapongsathorn, 2011) 
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and has been used to conceptualize treatment-seeking behaviors in depression (Elwy, Yeh, 
Worcester, & Eisen, 2011). The CSM has been previously supported in the diabetes 
literature and examined for representational qualities that are unique to, or consistent with, 
diabetes (Grzywacz et al., 2011; Searle, Norman, Thompson, & Vedhara, 2007). For 
example, a 2011 systematic review showed that previous studies have found significant 
associations between illness perception domains (specifically consequences, identity, 
timelines, coherence and emotional representations) and A1c (Mc Sharry et al., 2011). 
Additionally, interventions focused on targeting negative beliefs about diabetes have led 
to improved metabolic control (Snoek et al., 2001; as cited in Cameron & Leventhal, 
2003). These and other themes can be conceptualized within the components of the CSM. 
Prior research and implications will be discussed within the corresponding component 
below. It should be noted that discussion of a CSM related to SMBG is particularly 
complex given its dual relationship with the SRM. As mentioned previously, SMBG is 
primarily a method of feedback that begins the self-regulatory process of a separate 
health behavior. As such, the discussion of the common sense model of the SRM, below, 
will involve perceptions related to diabetes in addition to perceptions about self-
monitoring.  
Identity.  Identity refers to the identification with a disease or to the identity of an 
internal or external stimulus. Identification with diabetes as a personally experienced 
illness, rather than denial of the illness, would contribute to the perceived relevance of the 
other CSM elements. There has been some research support for a relationship between 
overall health perception and better adherence to SMBG; those who reported a lower or 
poorer perceived health status were more likely to engage in SMBG at least daily (Raffle, 
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Ware, Ruhil, Hamel-Lambert, & Denham, 2012). In other words, those who identified as 
being in poor health, or who had a stronger illness identity, were more likely to engage in 
this particular health behavior.   
“Internal” and “external” stimuli refer to any number of diabetes-related stimuli. 
Examples of internal stimuli include physiological sensations and glycemic awareness. 
Internal stimuli relate to perceptions of, and persistence with, SMBG. If an individual 
with T2DM feels they are able to perceive physiological sensations related to their blood 
glucose levels, they may be less likely to view SMBG as helpful. Also, if an individual 
does not sense changes in their blood glucose levels, they may be less likely to be 
prompted to test, unless they are using a structured testing schedule.  
Beliefs about internal stimuli may be supported by “sensitive soma” beliefs, or the 
degree to which an individual believes they are susceptible to sensing the effects 
(generally adverse effects) of medications (Diefenbach & Leventhal,1996). While 
individuals may consider physiological sensation to be a reliable and important form of 
feedback in illness, people are often mistaken about the actual meaning of internal 
sensations or the lack thereof. Blood glucose awareness is the main target of a successful 
intervention related to SMBG in adults with type 1 diabetes, Blood Glucose Awareness 
Training (BGAT; Cox et al., 2006). This training is aimed at improving a patients’ ability 
to regulate their blood glucose levels by way of an intervention that exposes them to the 
sensations they do, or do not, experience at different blood sugar levels. The intervention 
has been shown to improve blood glucose estimates and recognition of dangerous 
hypoglycemic and hyperglycemic episodes (Cox et al., 2006).  
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Examples of external stimuli in identity include the recommendation to engage in 
SMBG and information about diabetes, as provided in educational courses or through 
reading. Perhaps most important is the external stimuli provided by SMBG results. After 
an individual engages in SMBG, they are provided a number by their monitor that 
indicates their current blood glucose levels. If they choose to engage, or not engage, in 
behaviors in response to this number, they are initiating another cycle of self-regulation. 
This process depends on their understanding of purpose of SMBG and their 
understanding of diabetes and what they can do to raise, lower, or maintain their current 
glucose level. 
Cause. Cause refers to etiology beliefs, such as whether an illness is genetic, 
contracted, or injury-related. Diabetes-specific perceptions within cause have been 
examined in qualitative research and supported by further study. Cause perceptions tend 
to vary greatly between participants. In qualitative research, participants have described 
accurate beliefs, such as “diabetes runs in families,” (p. 325) and less accurate beliefs, 
such as “some people get diabetes because they ate too many sweets when they were 
young” (Grzywacz et al., 2011, p. 325).  
Little research has attended to ‘cause’ beliefs. Harrison and colleagues (2003) 
looked at cause beliefs in family members and found that perceived risk of disease 
development is considerably lower than actual risk in family members of a person with a 
positive family history of diabetes. In another study, Walter and Emery (2006) described 
T2DM as being generally viewed, in their sample, as an “illness of age” (p.475) and that 
it “felt less serious to many people who had experienced it among their relatives” (p. 475). 
Also, the participants who believed that T2DM is related to severe consequences tended 
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to endorse higher perceived self-risk of disease development. Overall, cause beliefs 
tended to vary dramatically by personal experience with the outcomes and experiences of 
people they knew with the illness. 
Timeline. Timeline refers to an understanding of the duration of a stimulus or 
illness. Timeline may also refer to the timescale of recovery from an illness (or lack of 
recovery). Perceptions of illness trajectory have been shown to relate to adherence in 
other diabetes literature. For example, viewing diabetes as a “non-chronic” condition 
diminishes the perceived importance of significant lifestyle alterations, and has been 
listed as a possible determinant of lack of adherence to treatments (Brown et al., 2002).  
Timeline may also refer to the duration of engaging in a management strategy, 
such as SMBG. Beliefs related to the perceived timeline of engaging in SMBG have not 
been reported in prior literature. It may also be that viewing diabetes as chronic leads to 
the perception that SMBG is a life-long commitment. This may lead the individual to be 
more likely to attempt to incorporate SMBG into their lifestyle. However having a 
chronic illness, such as diabetes, is related to elevated depressive symptomology, reports 
of burden, and, at times, avoidance of management behaviors (Renn, Feliciano, & Segal, 
2011). Short-term lifestyle adaptations may seem significantly more manageable to 
someone who is concerned about their ability to adapt self-management strategies into 
their lifestyle with little impact on their quality of life. As such, more chronic timeline 
beliefs about SMBG may relate to lower adherence behaviors.   
Consequences. Consequences refers to beliefs about the risks of the illness or 
treatment modality such as complications, and the possible impact on quality of life and 
life expectancy. The risks and long-term physiological complications of poorly managed 
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diabetes are well researched (CDC, 2011). However, research on complication- and 
consequence-perceptions related to diabetes is lacking. Surveys on awareness of diabetes 
complications suggest that many individuals with T2DM underestimate their risk for 
heart attack, heart disease and stroke (Bairey Merz, Buse, Tuncer, & Twillman, 2002). A 
recent meta-analytic review of illness perceptions and glycemic control highlighted 
consequences, measured by some form of the illness perceptions questionnaire 
(Broadbent, Petrie, Main, & Weinman, 2006), as one of the highest predictors of 
glycemic control and one of the highest predictors of psychological distress compared 
with other components of the CSM (Mc Sharry et al., 2011).  
Controllability. Since its conception, the SRM has been expanded to include two 
more components: controllability and coherence (Elwy et al., 2011). Controllability, also 
referred to as cure/control, refers to beliefs about the resources available to control the 
illness, including the different interventions available and their efficacy, as well as beliefs 
about an ability to cope with the illness or its side effects or complications (Petrie & 
Weinman, 1997). The combined term controllability reflects a singular construct while 
cure and control refer to treatment control and personal control, respectively. Prior 
research supports a two-dimension conceptualization, reflecting the cure and control as 
separate constructs. While personal control has been found to be negatively associated 
with glycemic control (R2 = -0.12), treatment control has not been consistently supported 
in the literature as related to glycemic control; this is possibly due to a lack of 
specification of treatments or not comparing those with using different treatment 
strategies (Mc Sharry et al., 2011). The control component of the CSM is likely more 
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cohesive in relation to SMBG, particularly in those who use SMBG as a strategy for 
improving personal control and when treatment strategy is consistent. 
In consideration of prior research findings, differences in treatment strategies, 
such as insulin or oral medications, should be considered when examining perceptions 
related to the ‘control’ component of the CSM. There are many treatment avenues for the 
physiological problems associated with T2DM; people tend differ in their beliefs about 
the most effective or appropriate regimen. As mentioned previously, the American 
Diabetes Association (ADA, 2012) and International Diabetes Federation (IDF, 2009) 
generally make vague care recommendations in domains in which research is not clear, 
such as for SMBG in T2DM. As such, it is expected that patient beliefs about the 
appropriateness of self-monitoring as a self-management strategy differ greatly across 
clinical settings. Nonetheless, most believe that some form of control is necessary (Lalic 
et al., 2012).  
Knowledge about the skills or strategies that can facilitate glucose control has 
been shown to be associated with better control (Zulman, Rosland, Choi, Langa, & 
Heisler, 2012). One study supported SMBG as a mediator between health literacy and 
better blood glucose control and also indicated that general diabetes knowledge 
accounted for much of the SMBG behaviors (Brega et al., 2012).  
Given the personal nature of self-regulation and a tendency to over-rely on 
personal experience, controllability beliefs are susceptible to change if self-collected 
evidence appears to contradict previously held beliefs. For example, a study conducted by 
Lawton and colleagues (2008; as cited in Gomersall, Madill, & Summers, 2011) found 
that patients who made lifestyle changes based on provider recommendations and did not 
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experience improvements in their condition or face further deterioration, tended to reject 
the grounds on which the provider made the recommendations and were less adherent to 
these and future recommendations. This finding has significant implications for those 
who are prescribed insulin to manage their diabetes. Traditionally, insulin therapy is 
reserved as treatment for T2DM only when other treatment regimens, such as oral 
medications, fail. It may be that individuals who continue to deteriorate despite 
significant lifestyle changes, and are given a prescription for subcutaneous insulin, have 
already experienced a significant blow to their understanding of the controllability of 
their illness. As a result, the importance placed on provider recommendations may be 
lowered or they may be less likely to regularly engage in self-management behaviors.          
 Controllability is one component of the SRM in which the concept of self-
efficacy (Bandura, 1977) may contribute to greater understanding of SMBG. Self-
efficacy theory suggests that a sense of failure related to previous diabetes-management 
skills would contribute to low self-efficacy for other diabetes management strategies. 
Indeed, diabetes-specific self-efficacy has been shown to be related to better glycemic 
control in T2DM (Zulman et al., 2012). An individual with low diabetes self-efficacy 
may be particularly hesitant to engage a strategy that requires a novel skill set or that 
could have negative consequences if done improperly. People may be hesitant to use 
SMBG as feedback for adjusting behavior due to concerns about making the right 
decisions. However, if an individual perceives SMBG to be relatively easy to engage in, 
to fit in to their lives, and feel confident about what to do in the event of a high or low 
reading, they may be more likely to engage in the behavior.  
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Additionally, glucose-monitoring format has been shown to impact maintenance 
behaviors. For example, the use of urine glucose monitoring has been linked to greater 
persistence as a strategy compared to SMBG, though quality of life was rated no 
differently than in the SMBG group (Lu et al., 2011). Alternative strategies should be 
considered in those with difficulty engaging in SMBG. 
Coherence. Coherence refers to the quality of understanding, or the degree to 
which an individual feels they understand, an illness. Few studies in chronic health 
identify this component of the CSM as a primary focus, or dedicate specific questions to 
it; however, self-regulation theory suggests that a person’s perceptions of the coherence 
of the illness could have great implications for treatment adherence. If an individual 
perceives their illness to be easily understood, they may be more likely to adapt their 
behaviors based on their own knowledge of the illness. One study identified that in their 
sample of individuals newly diagnosed with T2DM, 33% admitted that they did not 
understand diabetes and 73% were unclear about which symptoms might relate to 
diabetes or other health concerns (Davies, Lavalle-Gonzalez, Storms, & Gomis, 2008). If 
an illness is seen as confusing, the individual may feel apprehensive in instances 
requiring decision-making and experience affective distress or low self-efficacy.  
Psychosocial Factors and the Self-Regulation Model 
 Several studies have found associations between affective, psychological 
concerns (including diabetes-specific distress), and various physiological and treatment 
outcomes in diabetes. A 2001 meta-analysis revealed a well-supported, significant, 
positive relationship between depressive symptoms and incidence of diabetes 
complications such as diabetic retinopathy, neuropathy, macrovascular complications and 
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sexual dysfunction (De Groot, Anderson, Freedland, Clouse, & Lustman, 2001). A 2008 
meta-analysis found over forty articles supporting a positive relationship between 
depressive symptoms and diabetes treatment “non-adherence,” including medication 
treatment (Gonzalez et al., 2008b). While the mechanisms underlying these relationships 
are unclear, it is apparent that psychological distress is an important consideration in 
diabetes outcomes.   
Affect and coping. Unlike earlier models of health behavior (Rosenstock, 1974) 
the SRM considers affect as playing an important, ubiquitous role in the ongoing, 
moment-to-moment process of behavioral decision-making. According to the SRM, the 
process of health decision-making begins with a stimulus that is matched against both a 
person’s illness representation (or CSM) and their own affective response. These two 
elements interact and/or result in some form of coping, which, in turn, affects an outcome 
(see figure 1). This process is not viewed as linear. Instead, there is an understanding of a 
dynamic relationship between components; feedback from the initial process may act as 
another stimulus, or interact with either affect or the illness representation directly.  
Affect. The affective component of self-regulation is considered a process, which 
is methodologically difficult to capture given the potentially fleeting impact of affect. As 
such, affect would not be appropriately captured by a traditional self-report measure of 
mood, such as the Beck Depression Inventory (Beck & Steer, 1987), that asks about 
mood across the last 2 weeks. Given the inherent research challenges, few studies have 
examined affect as it relates to diabetes behaviors. It may be, however, that anticipated 
affect, such as fear or guilt, proves useful in determining affective processes related to 
SMBG. While this is easier to measure, it assumes the individual has a level of 
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psychological sophistication that enables them to reliably report associations between 
their mood states and behaviors. 
Several studies have shown a relationship between mood and perceptions of risk 
for health problems. These studies show that those who are happier report less perceived 
risk (Salovey, Rothman, Detweiler, & Wayne, 2000). This presents a complex issue, as 
risk perceptions have been shown to increase control efforts. However, self-efficacy and 
response efficacy, or expectations that behaviors maintain health, have both been 
supported as positively related to mood (Salovey et al., 2000) and potentially linked to an 
increase in control effort. These relationships are complex, but suggest that mood state 
can have a “nonconscious” effect on the CSM. This relationship is particularly relevant to 
self-regulation in diabetes as fluctuations in blood glucose levels are associated with 
idiosyncratic mood changes (Gonder-Frederick, Cox, Bobbitt, & Pennebaker, 1989); it 
could be that due to mood fluctuations an individual with T2DM is more susceptible to 
volatile self-regulation processes, particularly if their blood glucose is not well managed. 
This may result in a cycle of poor control and inadequate control efforts. However, it may 
be that this cycle can be managed with intentional “cool” focus on the dangers of not 
engaging in a health behavior rather than a “warm” focus on emotion (Cameron & 
Leventhal, 2003).   
Coping. Coping is one of the most critical elements of the self-regulation of 
illness behavior. Coping occurs between the illness representation component of self-
regulation and a health behavior (see figure 2). Coping is critical because it presents a 
potential barrier for self-regulation effort. For example, an individual can have a clear 
and accurate stimulus, such as a reading on the SMBG meter, and a great deal of 
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knowledge about the treatment of diabetes, but fail to engage in a proactive health 
behavior. In order to engage in a health behavior there must be a level of adaptive coping. 
If this person were having difficulty coping with their illness or other concerns, the 
process of self-regulation may be impaired.  
When examining coping as it relates to health behavior there are often a number 
of considerations as health behaviors can be affected by a range of concerns. In diabetes 
management, concerns can be behavior-specific (e.g. “I hate to stick myself”), diabetes-
specific (e.g. “I feel overwhelmed by my diabetes”), or broad (e.g. “I feel hopeless”). In 
diabetes, difficulty coping with concerns specific to diabetes management is referred to 
as diabetes distress. Distress is even more common in individuals with diabetes than 
depression (Beverly, 2014). Some studies indicate that over half of participants report 
some level of diabetes-specific distress (Gonzalez et al., 2007). Distress can also be 
specific to individual self-management components of diabetes management. Specific 
concerns related to SMBG that have been previously reported are barriers to testing due 
to negative mood, trouble with schedules, and hating to stick oneself (Stetson, Schlundt, 
Rothschild, Floyd, & Rogers, 2011). Broader reported diabetes distress concerns include 
worrying about complications and low blood sugar, feeling burned-out by the diabetes 
management regimen, and feeling depressed about having diabetes (Polonsky et al, 1995). 
The relationship between diabetes-specific distress and self-regulation strategies has been 
supported in previous research (Gonzalez et al., 2007). A recent study (Zulman et al., 
2012) showed that diabetes distress was associated with poorer glycemic control in 
individuals with T2DM, particularly when combined with poor self-management 
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strategies. This association suggests that there is a relationship between self-regulation 
and poor coping, although the nature of the relationship is unclear.  
Coping in the SRM is most certainly impacted by mental health concerns. 
Depression can be difficult to separate from diabetes distress and they often coexist 
(Gonzalez et al., 2007). Clinically-significant depression in diabetes tends to occur at two 
times the rate of that of the healthy population (Gonzalez et al., 2007). There is a 
proposed bidirectional relationship between diabetes and depression (Renn et al., 2011). 
There is evidence that depression results from the difficulties of managing diabetes and 
also evidence that the same biological predispositions that increase the likelihood of 
developing diabetes also predispose one to develop depression. This bidirectional 
relationship would implicate both biological and behavioral processes in shaping coping 
ability or functioning in diabetes self-regulation. The processes may impact illness 
representations as well. Skinner and colleagues (2011) found that depression, as 
measured by a depression screener (HANDS; Zigmond et al., as cited in Skinner et al., 
2011) was associated with CSM “cluster” membership. That is, depressed individuals 
were more likely to belong to a resisters accepting consequences cluster or a resisters 
cluster of CSM beliefs than more positive CSM clusters. Both clusters were related to 
perceptions of low personal responsibility (low personal control scores as measured on 
IPQ-R) and significantly higher A1c (Gonzalez, Delahanty, Safren, Meigs, & Grant, 
2008b). The findings suggest that depression may indirectly impact self-regulation by 
way of altering one’s self opinion; an individual who is depressed may view themselves 
as less capable of engaging in the self-regulatory process (Cameron & Leventhal, 2003). 
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Coping in self-regulation may be modified by the practice of self-management 
strategies, such as SMBG. There is some evidence that receiving negative feedback from 
the blood-glucose testing meter, such as consistently high or low values, can contribute to 
a sense of failure in someone engaging in SMBG (Gomersall et al., 2011). This may be a 
result of the context in which an individual receives feedback from their meter. As 
mentioned previously, when recommendations for SMBG timing and frequency are 
unclear, patients are left to select random time points to test. When SMBG readings are 
taken at inappropriate times, results are not meaningful (St. John et al., in press, as cited 
in Clar et al., 2010) or may lead to overly positive or negative perceptions of control. 
Unfortunately, even those who have strong self-regulation skills can have difficulty with 
choosing the appropriate behaviors when they are receiving deceiving feedback, which 
may lead to difficulty coping. Diabetes distress, in particular, may be a critical factor in 
the self-regulation process given the high degree of diabetes distress in previous research 
samples and consistent associations between distress and emotional and physical diabetes 
wellness (Beverly, 2014).  
Despite the tone of previously discussed findings, the challenges of coping with 
diabetes self-management practices are not insurmountable. Just as problems with coping 
and diabetes distress can lead to increased difficulty with managing diabetes and negative 
outcomes, effective coping can mitigate challenges and lead to improvements in both 
self-perception and physiological outcomes.   
Socio-demographic variables. The SRM has been developed with a 
consideration for an individuals’ broader socio-demographic context. Person factors, such 
as age and ethnicity, are considered to be highly important in shaping a person’s CSM 
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and self-regulation process. Diefenbach and Leventhal (1996) suggest that these factors 
“are more than just discrete variables, they are windows through which we can examine 
different processes” (p. 35). While some associations between socio-demographic 
variables and perceptions and behaviors related to SMBG have been revealed by prior 
research, this research is limited and little is known about the relationship between these 
factors.  
A recent meta-analysis, focused on qualitative studies of general diabetes self-
management, highlighted gender as contributing to different health practices 
(Gommersall et al., 2011). Generally, men report that they are more passive with diet and 
other self-management practices because they view the women in their lives as 
traditionally taking the responsibility for their diet; conversely, women were more likely 
to report that they did not engage in some management strategies because they were 
trying to accommodate other family members.       
A review of other health literature reveals that some socio-demographic variables, 
such as age, may critically impact illness perceptions. For example, Cameron & 
Leventhal (2003) found that the aging process may lead people to attribute symptoms to 
their aging body rather than illness. This belief has implications for self-regulatory 
decisions. If a symptom is attributed to aging, they are less likely to engage in a strategy 
to change it.   
   Another consideration is the secondary impact of socio-demographic variables, 
such as age and BMI. For example, both older adults and those with higher BMI levels 
have shown impairment in their hypoglycemic awareness (Berlin, Sachon, & Grimaldi, 
2005). Lower physiological awareness, or awareness that is complicated by symptoms 
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from other illnesses, can contribute to lower frequency and poorer quality of personal 
feedback and, therefore, poorer self-regulation.  
Social and contextual factors. Social input may be seen at all levels of the SRM. 
Social constructs, including the healthcare system and its practices, shape the 
recommendations for health and wellness. The CSM portion of the self-regulation model 
is dependent on a system of beliefs that come from a number of sources. These sources 
include institutions that make medical recommendations, research conducted and 
supported by a body of academics, representations of illness in the media, and other 
social influences. An individual may or may not ascribe to the beliefs of the predominant 
model of health related to diabetes, the medical model, which would support all treatment 
recommendations of the medical, such as are outline in the ADA (ADA, 2012) or IDF 
guidelines (IDF, 2009). 
Self-regulation skills are frequently shaped and supported by social learning, and 
cultural and societal values. For example, some cultures are more likely to endorse the 
belief that health management is the responsibility of the healthcare provider (Macaden & 
Clarke, 2006 as cited in Gommersall et al., 2011), a perception which may reduce 
likelihood of engaging in self-regulation processes related to health. Other cultures tend 
to have less difficulty finding strong support networks for facilitating self-management 
within their culture (Keval, 2009 as cited in Gommersall et al., 2011). A single cultural 
context can provide both benefits and drawbacks as it relates to successful self-
management. Collectivist cultures, for example, tend to be characterized by stronger 
community and social support but can also increase the likelihood that an individual will 
place the needs of their family members above the their own health needs (Chun & 
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Chesla, 2004; Chesla & Chun, 2005 as cited in Gommersall et al., 2011). Despite the 
evidence for a significant contribution, cultural beliefs alone do not predict self-
management practices. A study examining religious beliefs and diabetes self-
management practices found that some Christian individuals described a belief that their 
health and wellness was in the hands of God and adopted a passive relationship with their 
health, while others viewed God as a form of spiritual support and still felt actively 
responsible for engaging in health behaviors (Polzer & Miles, 2007 as cited in 
Gommersall et al., 2011).  
One of the most critical social influences in diabetes management that could 
presumably have a large impact on the self-regulation process is the health expert. 
Researchers and healthcare providers offer social input at nearly every component of the 
SRM. Healthcare experts impact an individual’s CSM of diabetes by way of providing 
information that could shape illness representation components (e.g., cause or 
controllability beliefs). Healthcare providers can also impact the individual context by 
prescribing treatment regimens such as whether or not SMBG is recommended or how 
frequently. One study, testing a conceptual model of provider style and diabetes self-
management practices in a large Veteran’s Affairs outpatient setting (Heisler, Bouknight, 
Hayward, & Smith, 2002), found a strong relationship between a provider’s 
communication style and patient barriers to adherence. Interestingly, the findings 
suggested that a patient’s understanding of diabetes care tended to mediate the 
relationship between physician style and adherence; specifically, a more communicative 
style and a more interactive style were both related to higher adherence, but only when 
patient understanding was also high. 
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There is a body of evidence that suggests diabetes practitioners are influential at 
the affective or coping levels of the SRM. For example, practitioners may avoid 
prescribing SMBG for fear of a patient’s inability to emotionally and logistically cope 
with the addition of another health care regimen. Given the high self-management 
demands of diabetes, the relationship between a patient and healthcare provider may be 
somewhat more complex than in other illnesses. As such, social interactions between 
patients and providers have been regularly studied in T2DM, though none within the 
context of SMBG alone. Research in diabetes populations points to a complex therapeutic 
relationship between patients and healthcare providers. Due to the complexity of these 
relationships, independent constructs, such as satisfaction or communication style, are not 
likely to singularly capture the social contribution of providers the SRM. Indeed, a large, 
translational research study, the Translating Research into Action for Diabetes (TRIAD) 
study, found no link between diabetes-specific physiological outcomes or health 
behaviors (TRIAD Study Group, 2002). A more recent, theory-based longitudinal study 
of individuals newly diagnosed with T2DM used physiological outcomes to examine 
factors attributed with significant changes (Nouwen et al., 2011). Interestingly, autonomy 
support, an important tenet of self-determination theory, was only important in a standard 
diabetes self-care model, not in a model looking at changes in A1c across time. This 
suggests that a healthcare provider who supports the individual as the most important 
factor in self-care decision-making, is perceived as ideal, but does not relate to 
improvements in physiological outcomes. A study by Lee & Lin (2009) supported an 
indirect impact of patient trust in a healthcare provider on adherence. Adherence to 
treatment recommendations was higher in those who rated a provider as positively 
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affecting their diabetes self-efficacy expectations and outcome expectations. The 
evidence in these studies points to the importance of not only provider style, but also the 
quality of the interaction between patient and HCP. While this relationship is complex, it 
can also be fruitful. Patients have cited their provider as facilitating reduced 
psychological distress related to making changes in self-managed health behaviors 
(Jenkins, Hallowell, Farmer, Holman, & Lawton, 2010).  
Summary 
In summary, the conceptual framework of the SRM has substantial utility in 
guiding understanding of SMBG in Type 2 diabetes. Illness perceptions, which may 
develop through social input and ones identity with diabetes and related stimuli, have 
particular relevance for SMBG and adaptation to life with a chronic disease. The 
individual components of the CSM, including causal beliefs, treatment timeline and 
illness consequences, may inform health-related behavioral decision-making, which is a 
critical part of chronic disease management. Diabetes self-management is widely 
recognized to require effective coping to manage the extensive demands of diabetes self-
management and affective responses to these and other concerns. Illness beliefs are 
shaped, and self-care behaviors influenced, by these considerations. Application of the 
SRM to SMBG, considering such illness-related perceptions as controllability and 
diabetes coherence, offers a conceptually driven approach to understanding SMBG as a 









PURPOSE OF THE PROPOSED STUDY 
The overarching purpose of the study is to examine the use of SMBG from a self-
regulatory theoretical perspective (Leventhal, 1970) and to understand its relationship to 
diabetes wellness. Specifically, this study aims to examine SMBG within the context of 
the illness perception construct of Leventhal’s CSM, focusing on the domains of 
controllability and coherence, and their associations with two aspects of diabetes wellness, 
diabetes distress and metabolic control.  
Specific Aims 
Aim I. A primary aim of this study is to examine the use of self-monitoring of 
blood glucose as a mediator in the relationship between diabetes illness perceptions and 
diabetes wellbeing, reflected by diabetes distress.  
a) To examine use of SMBG related to “controllability” as the predictor and 
diabetes-specific emotional coping as an outcome, and  
b) to examine the use of self-monitoring of blood glucose as a mediator in the 
relationship between diabetes illness perceptions related to “coherence” as the 
predictor and diabetes distress as the outcome. 
Aim II. A second aim of this study is to examine the use of self-monitoring of 
blood glucose as a mediator in the relationship between diabetes illness perceptions and 
diabetes wellbeing, reflected by metabolic control (A1c).  
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a) To examine use of SMBG related to “controllability” as the predictor and 
metabolic control (A1c) as an outcome and 
b) to examine the use of self-monitoring of blood glucose as a mediator in the 
relationship between diabetes illness perceptions related to “coherence” as the 
predictor and diabetes wellbeing reflected by metabolic control (A1c).  
Hypotheses 
 The study had a cross-sectional design with a number of hypotheses involving 
independent and dependent variables designed to accommodate the above aims. Specific 





















The research protocol was approved by the University of Louisville Institutional 
Review Board. The hospital-affiliated clinic recruitment site (Joslin Diabetes Center at 
Floyd Memorial Hospital and Health Services) deferred to the University of Louisville 
institutional review board for their recommendations and approval.     
Participant Selection  
 Participants for this study were men and women with Type 2 Diabetes who were 
prescribed subcutaneous insulin or daily injectable diabetes medication (e.g. Byetta) and 
were participating in ongoing care at the Joslin Diabetes Center (JDC) at Floyd Memorial 
Hospital and Health Services in New Albany, Indiana. The JDC offers both educational 
and clinical services that are specialized for individuals with diabetes mellitus. 
Participants were initially screened for a less inclusive range of age and prescription 
status; however, the screening criteria were expanded to reflect the typical age range of 
individuals with T2DM presenting for care at the JDC.  Revised inclusion criteria is as 
follows: (1) 21 years of age or older (2) a current diagnosis of Type 2 diabetes, (3) either 
prescribed subcutaneous insulin therapy or daily injected diabetes medication and (4) 
able to read and write in English. Given the lack of prior research focused on examining 
this particular model as it relates to SMBG, a relatively homogeneous sample (adults, not 
newly diagnosed with diabetes, some experience living with an injectable medication 
regimen) was chosen.  
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Incentive for Participation	  
 Participants who consented to participate in the study received a reusable plastic 
sport water bottle (nominal value) at the time they were given the questionnaire packet. 
Upon questionnaire return, participants were entered into a $250 cash lottery. 
Procedures 
Participant Recruitment. Participants were recruited for the study by research 
personnel (JW and trained graduate or undergraduate research assistants) while waiting 
for a scheduled blood draw appointment approximately one week in advance of a 
scheduled routine clinic appointment at the Joslin Diabetes Center outpatient clinic (JDC). 
Participants were recruited at the point of a blood draw appointment that occurred 
approximately one week prior to a provider visit. This point of recruitment was chosen to 
ensure that participant perceptions were not influenced by recent feedback from 
laboratory results, as this occurs during the provider visit at the JDC. All research 
personnel were compliant with Human Subjects Protection Program training 
requirements. Screening of potential subjects was completed by JDC medical staff or 
study investigators.  
Recruitment personnel received a list of eligible participants each morning at the 
clinic and were alerted when the patient arrived in the private blood draw area of the 
clinic. The potential participant was given a brief description of the study and a flier 
outlining the study and asked if they were interested in meeting with personnel to discuss 
the study details further in a private room following their blood draw. Private offices or 
clinic rooms in the JDC were used for study personnel to provide further study 
information including a description of the study, incentives and approximate time 
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commitment, and informed consent and HIPAA forms. The consent process was 
considered completed if the participant consented to the study and the consented 
participant was then provided with a packet of measures, signed copies of their consent 
forms, the water bottle incentive and instructions for returning the questionnaire packet in 
either (1) an unmarked, locked drop box in the JDC waiting area at the time of their 
follow-up appointment or (2) via the mail in a pre-addressed, pre-stamped return 
envelope. Questionnaire packets were marked with an ID number and no potentially 
identifying information to ensure privacy if the packet were misplaced in the mail or lost 
during attempted packet return. The research personnel then reminded the participant that 
their participation is voluntary and walked the patient to the checkout area of the clinic.  
Measures 
 See table 2 for a summary of measures used in the study. See appendix 2 for a 
packet of measures used in the study. 
Sociodemographic Information 
Sociodemographic questionnaire. Sociodemographic information was collected 
from all participants via a 12-item self-report questionnaire. Information requested 
included age, gender, race/ethnic background, height, weight, highest level of education 
completed, occupation, employment status, income bracket, marital status, and current 
living arrangement. For those consenting to medical chart access but failing to return the 
questionnaire packet, basic demographic information (age, sex) was collected from their 
medical chart.    
Medical Chart Data. Medical and health information for each consenting 
participant was gathered from either a computerized medical record or paper medical 
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chart and stored in a de-identified SPSS data file using a subject identification number. 
Any identifying information linking data to the participant was kept in a separate and 
locked location. Collected chart data included formal endocrinology diagnosis, 
month/year of diabetes diagnosis, diabetes-related prescription medication prescriptions 
(oral diabetes-related medications, exogenous insulin), changes in insulin prescriptions 
before and after baseline appointment, prescribed frequency of injected medication, 
frequency recommended for self-monitoring of blood glucose, medical comorbidities 
associated with diabetes (e.g., presence of cardiovascular disease, neuropathy, peripheral 
neuropathy, retinopathy), previous diabetes education opportunity use or referral, 
prescriptions for medical and mental health comorbidities, and lab data for a prior, 
baseline and follow-up appointment including A1c, fasting glucose level, lipids, height, 
and weight.          
Illness Representation  
Illness Perceptions Questionnaire – Revised (IPQ-R). Illness Representation was 
measured using the Illness Perceptions Questionnaire – Revised (IPQ-R) formatted for 
diabetes (Moss-Morris et al, 2002). The IPQ-R measure consists three sections: (1) An 
“Identity” section with 12 items, (2) a 38-item likert-type scale section and (3) an 18-item 
“cause beliefs” section with an additional cause ranking item. The first section contains a 
list of 12 common health symptoms (e.g., “headaches,” “dizziness”) and 2 sets of yes/no 
response options, the first to indicate whether they have experienced that symptom since 
diagnosis, the second to indicate whether they believe that symptom is related to diabetes. 
The second section consists of 38 statements related to diabetes perceptions (e.g. “there is 
a lot which I can do to control my symptoms”) and the third section contains a list of 18 
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possible causes of diabetes. Response options for the two, latter sections consist of five-
point “likert scale” response options: (0) “strongly disagree,” (1) “disagree,” (2) “neither 
agree nor disagree,” (3) “agree,” and (4) “strongly agree.” The ranking item at the end of 
the third section allows short, open-responses to the prompt: “In the table below, please 
list in rank-order the three most important factors that you now believe caused YOUR 
diabetes. You may use any of the items from the box above, or you many have additional 
ideas of your own.” 
The portion of the measure used for analysis in this study consisted of 17 items, 
12 items specifically related to diabetes “controllability” perceptions, divided between 
treatment and personal control, and 5 items related to diabetes “coherence.”  
Research has supported the IPQ-R as having acceptable to excellent reliability 
(Coherence, 0.50-0.90; Control, 0.53-0.86) (Moss-Morris et al., 2002; Skinner et al., 
2011), and it has been used to measure change in illness perceptions in previous diabetes 
research trials (Davies et al., 2008; Skinner et al., 2011).   
Self-Monitoring of Blood Glucose  
Self-monitoring of blood glucose decision-making. There are few tools that 
measure the decision-making utility of SMBG. The measures that exist tend to focus on 
one aspect of decision-making, such as the use of SMBG in the process of avoiding a 
hyperglycemic event (HAS). As such, a one-item measure developed for a research trial, 
in progress, was used (D. Cox, personal communication, August 31st, 2012). The item is 
as follows: “To what extent are you using your blood sugar testing to decide what to do, 
like what to eat or how to be physically active, to manage your diabetes?” The response 
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options for this item range from “0”-“4” with “0” indicating “not at all” and “4” 
indicating “extremely.”    
Self-monitoring of blood glucose frequency. The Summary of Diabetes Self-Care 
Activities measure (SDSCA) was used to measure the frequency of engaging in blood 
glucose self-monitoring behaviors. The SDSCA is a brief, self-report measure designed 
for assessing diabetes self-care behaviors in both T1DM and T2DM. The measure 
prompts for the number of days in a given week that an individual engages in specific 
health behaviors, including the core self-management behaviors recommended by the 
ADA (ADA, 2012) and IDF (IDF, 2009).  There are 11 items on the revised SDSCA that 
address behavioral domains including diet, exercise, blood glucose testing, foot care and 
smoking. The eight response options range from 0 to 7, representing the number of days 
in a given week that the individual engaged in that particular behavior.  
Research has suggested that the SDSCA demonstrates moderate validity and 
acceptable inter-item and test-retest reliability (Toobert, Hampson & Glascow, 2000). 
Because items are designed to each measure an independent behavior, high reliability is 
not desired. The SDSCA has been previously used in studies that examine personal 
models of diabetes (Deakin, Cade, Williams, & Greenwood, 2006; Hampson, Glascow, 
& Toobert, 1990; Khunti et al., 2008). Only the three items related to blood glucose 
testing frequency were used in this study.  
Diabetes distress 
Problem Areas in Diabetes scale (PAID). The Problem Areas in Diabetes scale 
(PAID) was originally developed by Polonsky and Colleagues (1995) as a 20-item, single 
factor, self-report measure to assess diabetes distress in both clinical and research 
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samples of individuals with diabetes. Specific items relate to feelings, perceptions and 
mood related to their general care regimen and living with diabetes. It is proposed that the 
construct measured by the sum of these responses is overall “emotional functioning” 
specific to diabetes (Polonsky et al., 1995), or level of diabetes distress, and has been 
used in medical research trials as a quality of life outcome (Davies et al., 2008). It 
continues to be the most frequently used, and recommended, measure of diabetes distress 
in the literature (Beverly, 2014).  
Each item in the PAID has a response option ranging from “0” (“not a problem”) 
to “4” (“always problem”). The total score is a summation of items that can be 
transformed so that scores range from 0-100 with a higher score indicating the perception 
of more significant and frequently encountered problems. The PAID has been found to 
have high internal consistency (α= .90) and sufficient test-retest reliability (r = .83) 
(Welch, Weinger, Anderson, & Polonsky, 2003). Scores on the PAID have been shown to 
be relatively consistent across groups, including age groups, duration of diabetes, 
education level, ethnicity and gender (Welch et al, 2003). PAID scores have been shown 
to differ between those with T1DM and T2DM diabetes but not between insulin groups 
(Welch, Jacobson, & Polonsky,1997). 
          Consideration of background variables and their associations with primary  
study constructs. Previous research consistently supports differences in diabetes related 
behaviors and perceptions by gender, duration since diagnosis (Gomersall et al., 2011; 
Primozic et al., 2012), and insulin prescription status (Hampson et al., 1990). Gender 
differences are typically thought to interact with the process of self-regulation while age 
differences are thought to interact more directly with the common sense model. Gender 
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and age were both assessed along with basic demographic information including 
socioeconomic status, educational attainment, employment and disability status and 
living arrangements. 
T-tests or Mann-Whitney U tests or correlation tests (Pearson’s or Spearman’s 
Rho) were conducted to examine relationship of demographic and background variables 
with each of the independent, dependent and mediator variables. Any comparisons 
revealing significant differences were followed by an approach of entering that variable 
into regression equations in a separate block to control for its influence.  
Data Analysis 
Statistical analyses for descriptive information. In order to characterize the 
sample, a number of descriptive and univariate analyses were conducted using SPSS 
software version 21 (IBM Corp, 2012). Descriptive statistics included mean, standard 
deviation and frequency count of variables in an effort to describe the sample and check 
for outliers and out of range data. Binomial tests, such as Chi-square, were conducted to 
examine relationships between multiple discrete variables. Analyses of Variance 
(ANOVAs) and t-tests, where appropriate, were utilized to compare continuous variables 
based on divided or dichotomized sample characteristics (such as “controllability” 
perceptions by gender). In addition, parametric and non-parametric (Pearson and 
Spearman’s Rho) correlation statistics were used to examine the relationship between 
variables (such as “controllability” perceptions and “coherence” perceptions), in order to 
consider applicability to past and future studies.   
Hypothesis testing 
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Aim I.  The primary aim of this study included examining the indirect relationship 
of illness perceptions related to “controllability” and diabetes distress through the use of 
self-monitoring of blood glucose, defined as two distinct properties of monitoring 
behavior—the use of monitoring as a decision-making strategy and the frequency of 
monitoring. This relationship was also examined for illness perceptions related to 
“coherence” in place of “controllability.” See table 1 for planned statistical hypotheses 
corresponding to each theoretical hypothesis.     
Hypothesis 1 (H1): Beliefs reflecting greater illness controllability will be 
indirectly associated with less diabetes distress (by way of both increased self-monitoring 
decision-making and higher frequency of testing).  
The testing of this hypothesis (H1) was planned to be conducted in accordance 
with the joint significance test of mediation outlined by Taylor and colleagues (2008). 
The joint significance test has been shown to afford a high statistical power while 
maintaining a low type 1 error rate and was recommended as superior to other two-
mediator models. Testing H1 will consist of the use of three, separate linear regression 
tests to examine three separate pathways, followed by a series of critical value 
comparisons. The first pathway involves testing the regression of SMBG decision-
making and controllability scores with the SMBG decision-making item as the dependent 
variable and scores on the personal or treatment controllability subscales of the IPQ-R 
(12-items) as the predictor variable. The second pathway involves regressing the 
frequency of SMBG (measured by the SDSCA) as the dependent variable and SMBG 
decision-making and controllability beliefs (IPQ-R) as the predictor variables. The final 
path involves a regression with emotional coping (PAID) as the dependent variable and 
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controllability beliefs, SMBG frequency and SMBG decision-making as the predictor 
variables. Then, critical values for each regressive relationship were planned to be 
calculated (dividing a beta weight by its own standard error) and compared with critical 
values for a two-tailed t-statistic (t.975(n-2)) given a specific degree of freedom. The 
degrees of freedom decrease by one degree with each subsequent comparison). The null 
hypothesis is rejected if each calculated value (bx/sbx) is greater than the critical t-statistic 
value. See table 1 for a summary of the statistical equations and pathways for the joint 
significance test. See figures 2 for a figural representation of the joint significance model 
with the variables from the proposed study mapped onto it. See figure 3 for the original, 
proposed SPSS analysis plan and data planned for final hypothesis testing. 
Hypothesis 2 (H2): Beliefs reflecting greater illness coherence will be indirectly 
associated with less diabetes distress (by way of both increased self-monitoring decision-
making and higher frequency of testing). 
 The testing of this hypothesis (H2) was planned to be conducted in accordance 
with the joint significance test of mediation outlined by Taylor and colleagues (2008), as 
described above. See table 1. 
Aim II. A secondary aim of this study includes examining the indirect 
relationship of illness perceptions related to “controllability” on A1c through the use of 
self-monitoring of blood glucose, defined as two distinct properties of monitoring 
behavior—the use of monitoring as a decision-making strategy and the frequency of 
monitoring. The relationship was planned to be tested with the “coherence” subscale of 
the IPQ-R in place of “controllability.”     
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Hypothesis 3 (H3): Beliefs reflecting greater illness controllability will be 
indirectly associated with lower hemoglobin A1c (by way of both higher decision-making 
and self-monitoring frequency).  
Hypothesis 4 (H4): Beliefs reflecting greater illness coherence will be indirectly 
associated with lower hemoglobin A1c (by way of both higher decision-making and self-
monitoring frequency).     
These hypotheses (H3 and H4) were also planned to be tested in accordance with 
the joint significance test of mediation, described above. See table 1.   
Sample size calculation. Taylor and colleagues (2008) conducted simulations to 
estimate the Type 1 error rate and power afforded by the joint significance test for a 
series of predetermined (N= 50, 100, 200, 500 and 1,000) sample sizes and effect sizes 
(small, medium and large).  As the joint significance test is a path mediation model, 
effect size estimates for each tested path can be multiplied and compared with simulated 
sample sizes to yield an estimate of power and Type 1 error rate. Based on prior related 
research it was estimated that the proposed study would yield a small to medium effect 
size (Cohen, 1992). A systematic literature review reported study characteristics for five 
studies comparing SMBG alone (without instructions) to SMBG with an educational 
feedback intervention and increased testing frequency (Clar et al., 2010). Effect sizes 
were calculated for the reported studies; effect sizes ranged from d=0.19 to d=0.50 using 
G*Power (Faul, Erdfelder, Buchner, & Lang, 2009). The simulations conducted by 
Taylor and colleagues (2008) support the joint significance test as yielding a Type 1 error 
rate of less than .0060 and a power of .9120 for a sample size of 100 participants for an 
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expected medium effect size (d=0.36) and Type 1 error rate of .0020 and a power of 
0.772 for a small effect size (d=0.14) (MacKinnon et al., 2002).  
Based on data from previous studies of persons living with T2DM collected at the 
JDC and standard estimates, it was anticipated that 20% of the collected data would be 
missing or unusable. In addition, recruitment and retention data from a previous study at 
this site found that 27% of individuals who consented to participate did not actually 
return the completed data packet. However, this study did not include a monetary 
incentive. Given this available data, prior to the study the recruitment target was set at 





















This section begins with a description of study participants and response rates. 
Following this will be a description of data analysis preparation and a summary of 
descriptive analyses and data concerns. The results of the original statistical plan for the 
study’s four hypotheses will be discussed followed by a summary of an adjusted plan 
based on unforeseen data concerns, and results of the adjusted plan, by hypothesis. 
Finally, a number of additional, supplementary analyses examining other relationships 
between primary study variables will be described. 
Participant Characteristics 
The next few sections present participant characteristics (N=185) including a 
review of data completion and participant demographics and responses separated into 
domains for clarity.  
Recruitment and return rates. Participant screening and recruitment numbers 
are presented in Figure 5. Of those patients at the JDC who were screened for the study, 
the majority were ineligible due to not having a type 2 diabetes diagnosis with many 
others not eligible due to not being prescribed insulin (likely treated with oral 
medications alone or managed with diet and exercise). Of those deemed eligible by chart 
review, the majority were not approached by research personnel; this was most often 
related to not having an available research assistant during the time the potential 
participant presented for the blood draw.  
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Of those eligible patients approached by research personnel, the majority agreed 
to hear more about the study and consented to participate. Of those who declined to hear 
more about the study or to participate, the majority stated that they were ‘in a hurry,’ 
which includes responses such as “I am on my way to work and will be late,” “I am 
fasting and hungry and can’t wait to eat,” or “I don’t have time.” Other reasons cited for 
not being interested in the study included discomfort with medical chart information used 
in the study or concerns about the time needed to complete the packet. 
Of those consenting to complete the study, close to one quarter did not return their 
baseline questionnaire packet (27.02%). Though limited demographic data is available 
for those who did not return a baseline questionnaire packet, medical chart data was 
obtained to allow for group comparison. Participants were not found to differ by age, 
body mass index, blood glucose level or A1c at prior or baseline appointments using t-
test statistics (see table 5). Participants were not found to differ by sex/gender using chi-
square analysis (X2(1)=.121, p=.728).  
A small number of consented participants chose to revoke their authorization for 
collection of data (4.3%) and another small number were found to be ineligible during 
medical chart review either due to no clearly documented insulin prescription or a formal 
diagnosis of T1DM (2.2%). 
Data completion. Of those returning baseline packets, the majority of items were 
completed in full. The most commonly skipped items from primary variables were 
related to treatment control beliefs (IPQ, n=7), SMBG decision-making (n=6), illness 
coherence (IPQ; n=4) and diabetes coping (PAID; n=4). For the Problem Area in 
Diabetes scale (PAID), means replacement was used for up to three items; means 
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replacement was used for a very small number of participants (n=6). Additionally, the 
Illness Perceptions Questionnaire subscale related to control beliefs was divided into 
personal control beliefs and treatment control beliefs; the treatment control subscale had 
more missing data. Otherwise, cases were excluded listwise, meaning the participant’s 
data was excluded for an entire case on an analysis-by-analysis basis. Using this method, 
the minimum number providing responses for planned statistical tests of the main 
hypotheses was N=105, therefore, sufficient power was achieved in accordance with 
simulations conducted by Taylor and colleagues (2008) for the joint significance test for 
a predicted Type 1 error rate of less than .0060 and a power of .9120 for an expected 
medium effect size (d=0.36) and predicted Type 1 error rate of .0020 and a power of 
0.772 for a small effect size (d=0.14) (MacKinnon et al., 2002). For analyses involving 
an additional variable, treatment control (IPQ), the power may be reduced due to missing 
item responses (N=96).   
Characteristics of participants who returned questionnaires. A summary of 
demographic and descriptive information for the study participants can be found in table 
3. Participant demographics presented here are for those returning baseline packets and 
were confirmed as eligible to complete the study (N=124) as those who did not return 
their baseline packet have less demographic data available and are not included in the 
primary analyses. An analysis of differences between consented participants who 
returned the questionnaire packet and those who did not is discussed at the end of this 
section.  
Socio-demographic variables. Participants were predominantly White Americans 
(n=115, 93.5%), which is consistent with recent area census data which indicates that 
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Floyd County residents are comprised of 90.4% White American, 5.2% Black or African 
American, 0.2% Native American, 0.9% Asian, 0.2% Pacific Islander, 1.2% from other 
races, and 2.1% from two or more races. 2.6% of the population were Hispanic or Latino 
of any race (US Census, 2010). Participant gender was nearly evenly split in this sample. 
Ages ranged from 34 to 86 years-of-age. The majority of participants endorsed that they 
are currently married with at least high school grade level education or equivalent. There 
was a range of income levels reported though most were either disabled or retired. 
Habitation classification varied with most living with a spouse or partner.  
Diabetes-related characteristics. The following characteristics are reported in 
table 3.  
Diabetes illness characteristics. There was a broad range of duration of diagnosis 
(from 2 to 40 years) and onset of insulin prescription (from 1 to 27 years). There is 
significant missing data for these variables as the onsets of the diabetes diagnosis was not 
always noted in the medical chart. The modal result for insulin prescription was four 
insulin injections daily. The modal result for times per day recommended to SMBG was 
3.5 times daily (recommended as 3-4 times per day), though SMBG frequency 
recommendations were not always noted in the medical chart. Most participants were 
also prescribed oral diabetes medications. Most participants had many health 
comorbidities including hypertension (n=104, 7.3% missing data), heart disease (n=24, 
43.5% missing data), hyperlipidemia (n=113, 6.5% missing data), and peripheral 
neuropathy (n=56, 22.6% missing data). The missing data for these variables is due to a 
change in medical chart data collection practices partially through the data collection 
process.  
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Diabetes health practices. Participants indicated a range of adherence to health 
recommendations for diabetes self-care, as measured by the SDSCA (see table 6). Very 
few participants endorsed smoking even one puff of a cigarette in the last week. General 
adherence with oral diabetes medications was higher than adherence to guidelines for 
frequency of insulin injections, as measured by days in the last week the medications 
were taken as recommended. There was a range in responses related to how frequently 
participants are engaging in recommended diet plans, though several reported following 
recommended diet plans less than half of the previous week. Most participants reported 
that they engaged in a level of physical activity below the amount recommended by the 
American Diabetes Association standards of medical care in diabetes (ADA, 2012), with 
the majority engaging in physical activity (at least 30 minutes) only two days per week or 
less with no planned physical activity sessions.  
Most participants had a history of attending Diabetes Self Management Education 
and many also had a history of Medical Nutrition Therapy (see table 3).  
Mental health chart data. A small percentage of participants had a diagnosis of 
a mental health condition in their medical chart including a depressive (n=7), anxiety 
(n=4,) or bipolar (n=1) disorder. A larger percentage were prescribed an antidepressant 
(n=36) anxiolytic (n=9) or mood stabilizer (n=7).  
Primary Study Variables  
Primary study variables were examined for their ranges, mean, medians, modes, 
standard deviations and response distributions and compared with other samples found in 
the diabetes literature (see table 7). Variables were also examined for missing data, 
distribution normality, and outliers.   
  
	   48 
Illness perceptions 
Personal control beliefs. Responses on IPQ items in the Personal Control Beliefs 
subscale were completed by participants with missing values for four cases. Data were 
not imputed due to the small number of items in this scale (6) and data was excluded 
from subsequent analyses. Responses yielded a range of scores from 17 to 30 from a 
possible range of 0 – 30. This response range from this sample indicates that all 
participants reported that they consider their personal actions as having at least some 
impact on their diabetes outcomes, such as illness complications. The distribution of 
responses was moderately negatively skewed with high mean scores and a modal score of 
30, indicating beliefs that personal behaviors are very important for diabetes symptoms or 
outcomes (see table 7). As such the variable was transformed using a square root 
equation for use in regression analyses in accordance with recommendations from 
Howell (2010) with a resulting reduction in the negative skew. Non-parametric statistics 
were used for all other analyses (Mann-Whitney U-test, Kruskal-Wallis H-test, or 
Spearman’s Rho correlation).     
Treatment control beliefs. Responses on the IPQ items that related to treatment 
control beliefs were completed by participants with missing data for 8 cases. Missing data 
was not imputed due to small number of items in the scale (5) and incomplete data was 
excluded from subsequent analyses. Responses resulted in a relatively normal distribution 
of scores. Scores ranged from 10 to 25, from a possible scores range of 0 – 25, indicating 
that all participants reported at least some degree of belief that control of their diabetes is 
possible.  
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Diabetes coherence beliefs. Responses on the IPQ items from the illness 
coherence subscale resulted in a mildly negatively skewed distribution. Five participants 
failed to respond to items within this subscale; data was not imputed due to a small 
number of items in the scale (5) and the missing cases were excluded for subsequent 
analyses. Participant responses yielded scores ranging from 5 to 25 (subscale possible 
scores range from 0 – 25), reflecting a broad range of reported personal understanding of 
diabetes, though the modal score was 25.  
Self-monitoring of blood glucose behaviors  
Self-monitoring of blood glucose frequency. Self-monitoring of blood glucose 
frequency was measured by an SDSCA item that asked about days of use of SMBG in the 
prior week. This variable was found to be significantly negatively skewed with most 
participants reporting daily use over the previous week (61.0%). Responses ranged from 
0 days to 7 days. See table 7 for response results. Transformations of data were not 
successful in reducing skew. As such, this variable is inappropriate for use in regression 
analyses as a continuous variable. For regression analyses this variable will be collapsed 
into those testing at least 5 days per week (n=95) and all others (n=28). Only those in the 
first group (testing at least 5 days per week) will be considered in regression analyses for 
hypothesis testing.  
Self-monitoring of blood glucose adherence. Self-monitoring of blood glucose 
adherence was measured by an SDSCA item that asked about days of use of SMBG ‘the 
number of times recommended’ in the prior week. Most reported SMBG at least daily in 
the past week though several reported that they did not test the number of times 
recommended by their provider. Due to the wording of the question and noted range of 
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recommending practices noted in medical charts, it cannot be assumed that these 
individuals are testing less often than recommended. See table 7 for response results.  
Self-monitoring of blood glucose use as a decision-making tool. Self-monitoring 
of blood glucose decision-making is measured by a single, self-report likert-type item 
reflecting extent to which the participant feels they are using their SMBG result to make 
decisions about their health behaviors and diabetes self-care. Responses ranged from 0 
(not at all) to 4 (extremely) with that modal response at 3 (a great deal; n=43). Seven 
participants (n=7) who returned a packet failed to respond to the item.  Mean values were 
similar, falling between 2 (a moderate amount) and 3 (a great deal). A normality statistic 
found the variable to be significantly negatively skewed. However, as non-parametric 
tests will be used, the data was not transformed for analyses. Ordinal regression 
techniques (Polytomous Universal Model; PLUM) with SMBG decision-making as a 
dependent variable and each primary variable as a separate independent variable were 
used to test for violation of assumptions. No violations were found and variable was used 
in regression analyses without transformation or recoding. No outliers were found and all 
cases were retained for analyses (see table 7).    
Diabetes distress. The Problem Areas in Diabetes scale (PAID) was used as a 
measure of diabetes distress. Four participants left a significant number of items blank 
and were removed from subsequent analyses and 6 participants had means replacement 
for up to three items (4 needed means replacement for 1 item, 1 needed means 
replacement for 2 items, and 1 needed means replacement for all 3 items). The PAID 
scores from this sample of participants were normally distributed with no outliers. Mean 
PAID scores (M=25.85, sd=14.34) were similar to an original normative sample of 
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individuals with Type 2 diabetes on insulin therapy (M=26.4, sd=20.8) but had a 
narrower standard deviation (Welch et al.,1997). All valid cases were retained for 
analyses.    
Physiological blood glucose control. Blood glucose control was measured by 
A1c blood serum level (%) drawn at the point of recruitment. Participants were not aware 
of their A1c at the time of packet completion. Participants were generally poorly 
controlled, which is consistent with individuals with Type 2 diabetes who require insulin 
therapies. See table 3 for descriptive information. 
Examination of individual values revealed a range from 5.0% (good control) to 
15.9% (very poor control). Tests of normality revealed a significant positive skew. Given 
that the maximum value (15.9%) is significantly higher than the immediately preceding 
value of 12.5%, the maximum value was removed as an outlier, which led to a more 
normal frequency distribution.  
Differences in Psycho-Socio-Demographic Variables Among Primary Study 
Variables 
Differences in primary study variables were examined using Pearson and 
Spearman’s Rho correlations, T-test, or Mann-Whitney U (see tables 3 and 7). Age was 
found to be significantly negatively correlated with PAID scores and no other primary 
variables. Prescribed insulin frequency was found to be significantly positively correlated 
with SMBG use as a decision-making strategy and no other variables. Time since insulin 
prescription was negatively correlated with treatment control beliefs. Months since 
diabetes onset and frequency recommendations for SMBG were not found to be 
associated with primary variables.  
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Other demographic variables were collapsed into two groups for comparison (see 
table 3). Differences were found between marital status groups (currently married vs. not 
currently married) for A1c with those married having better control. Differences were 
found between education groups with those having at least some college education 
reporting higher coherence and greater personal control beliefs than those with a high 
school diploma or less education. Differences were found between low income and mid 
to high-income groups (low income defined as currently married and under 30,000 
annual household income or not married and under 20,000 annual household income) 
with those reporting lower annual household income also reporting lower mean 
coherence. No differences were found between gender groups, a dichotomized work 
group full-time vs. other, or those on antidepressants vs. those who are not. Ethnicity was 
not examined due to the largely homogeneous nature of the sample ethnicity. 
Self-reported health practices (SDSCA) were examined for associations with 
primary study variables. Coherence and personal control beliefs were both positively 
associated with reports of following an eating plan and coherence beliefs was also 
positively associated with taking recommended number of insulin injections and spacing 
carbohydrate consumption across the day, see table 6. Treatment control beliefs were 
positively associated with taking a recommended number of diabetes pills and eating 
fruits and vegetables. Use of SMBG decision-making was positively associated with 
frequency of taking injections as recommended and frequency of following a number of 
meal plans including following a healthy eating plan, eating fruits and vegetables, and 
spacing carbohydrates and negatively associated with frequency of eating food high in fat. 
Diabetes distress (PAID) was found to be negatively associated with diet behaviors 
  
	   53 
including following an eating plan and spacing carbohydrates. Actual glucose control, as 
measured by A1c lab at baseline, was negatively associated with following a healthy 
eating plan and spacing carbohydrate and positively associated with a diet high in fats.  
Hypothesis Testing  
The initial statistical plan (see table 1 for the original data analytic plan divided by 
statistical hypothesis) was revised due to significant non-normal distribution of one of the 
study’s primary variables, SMBG frequency. As a predicted joint mediator, SMBG 
frequency was present in the statistical plan for the testing of all hypotheses. Simple 
indirect effects tests, as described in Baron & Kenny’s model of mediation (1986) were 
conducted considering the relationships between the remaining three variables with the 
same predictor, mediator, and outcome variables as outlined in the original statistical plan 
with the exclusion of SMBG frequency (See figure 4 for a figural representation of the 
revised, proposed indirect effect pathways). Baron & Kenny’s model involves the testing 
of four separate regression relationships. The initial proposed relationship must be 
supported before subsequent relationships are tested. In order to account for SMBG 
frequency as part of the hypothesized relationship, the sample used in the analyses was 
selected based on responses from the SMBG frequency variable with only those who 
reported that they SMBG at least 5 out of 7 days (n=95) being considered for each 
regression.  
Hypothesis 1 
Hypothesis 1 (H1): Beliefs reflecting greater illness controllability will be 
indirectly associated with more successful emotional coping (by way of both increased 
self-monitoring decision-making and higher frequency of testing).  
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Hypothesis 1 was tested using two separate indirect effect pathways (Baron & 
Kenny, 1986) with PAID scores as the outcome variable (Y), SMBG decision-making as 
the predicated statistical mediator (M), and treatment control beliefs (IPQ) as one 
predictor variable (X) and personal control beliefs (IPQ) as a separate predictor variable 
(X).  
The first step in the first predicted pathway, testing whether personal control 
beliefs (IPQ) significantly account for variance in PAID scores, controlling for habitation 
status and education level, was not supported. No further relationships were tested in this 
indirect effects model. See table 8 for a summary of regression results.   
The first step in the second predicted pathway, testing whether treatment control 
beliefs (IPQ) significantly predict PAID scores was not supported. No further 
relationships were tested in this indirect effects model. See table 8 for a summary of 
regression results.   
Hypothesis 2 
Hypothesis 2 (H2): Beliefs reflecting greater illness coherence will be indirectly 
associated with more successful emotional coping (by way of both increased self-
monitoring decision-making and higher frequency of testing). 
Hypothesis 2 was tested using an indirect effects model (Baron & Kenny, 1986) 
with PAID scores as the outcome variable (Y), SMBG decision-making as the predicated 
statistical mediator (M), and illness coherence beliefs (IPQ) as the predictor variable (X).   
The first step in the predicted pathway, testing whether illness coherence beliefs 
(IPQ) significantly account for variance in PAID scores, controlling for education and 
SES level, was supported (p<.001). The second step in the predicted pathway, testing 
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whether illness coherence beliefs (IPQ) significantly account for variance in SMBG 
decision-making, was supported (p=.044). The third step in the predicted pathway, testing 
whether both SMBG decision-making and illness coherence beliefs (IPQ) as a group 
account for variance in PAID scores was supported (p=.004). The final step, testing 
whether the relationship between illness coherence beliefs is no longer significant after 
controlling for SMBG decision-making was not supported; the relationship remained 
significant (p=.001). See table 9 for a summary of regression results.  
Hypothesis 3 
Hypothesis 3 (H3): Beliefs reflecting greater illness controllability will be 
indirectly associated with lower hemoglobin A1c (by way of both higher decision-making 
and self-monitoring frequency).  
Hypothesis 3 was tested using two separate indirect effects pathways (Baron & 
Kenny, 1986) with A1c at baseline as the outcome variable (Y), SMBG decision-making 
as the predicated statistical mediator (M), and treatment control beliefs (IPQ) as one 
predictor variable (X) and personal control beliefs (IPQ) as a separate predictor variable 
(X).   
The first step in the first predicted pathway, testing whether personal control 
beliefs (IPQ) significantly account for variance in A1c, controlling for habitation status 
and education level at baseline, was not supported. No further relationships were tested in 
this indirect effects model. See table 10 for a summary of regression results.   
The first step in the second predicted pathway, testing whether treatment control 
beliefs (IPQ) significantly predict  at baseline was not supported. No further relationships 
were tested in this indirect effects model. See table 10 for a summary of regression results.   
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Hypothesis 4 
Hypothesis 4 (H4): Beliefs reflecting greater illness coherence will be indirectly 
associated with lower hemoglobin A1c (by way of both higher decision-making and self-
monitoring frequency).     
Hypothesis 4 was tested using a indirect effects model (Baron & Kenny, 1986) 
with A1c as the outcome variable (Y), SMBG decision-making as the predicated 
statistical mediator (M), and illness coherence beliefs (IPQ) as the predictor variable (X).   
The first step in the predicted pathway, testing whether illness coherence beliefs 
(IPQ) significantly account for variance in A1c at baseline was not supported. No further 
relationships were tested in this indirect effects model. See table 11 for a summary of 
regression results.   
Supplemental Analyses 
 Given the lack of support for all hypotheses, indirect effects tests were run 
considering all SMBG frequency testers instead of limiting the tests to the selected 
sample of those only reporting SMBG 5 to 7 days per week. With the expanded sample, 
none of the hypothesized indirect effect relationships were supported.   
 Indirect effects tests were also run for the reverse indirect relationships. That is, 
those variables previously considered outcomes (Y) were examined for possible indirect 
effects on those variables previously considered predictor variables (X) through SMBG 
decision-making, see Figure 6. None of the hypothesized indirect effects were supported.    
Primary study variable associations. Primary study variables were examined for 
basic associations with one another using correlations. Items related to SMBG or 
personal control used a Spearman’s Rho statistic due to data type or non-normal 
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distribution; all other items used a Pearson’s r statistic. Associations were found between 
a number of variables, see table 7 for correlation results.  
All SMBG items were found to have a moderate to strong positive correlation 
with one another (p<.001). SMBG decision-making use was found to also be related to 
illness perceptions, including a positive relationship with personal control and coherence 
beliefs but not treatment control, and a negative relationship with both outcome variables 
(A1c at baseline and PAID score). SMBG frequency was not found to be correlated with 
additional primary variables. SMBG adherence to recommended daily frequency was 
found to also be weakly positively correlated with treatment control beliefs and weakly 
negatively correlated with PAID scores.  
Illness perceptions related to treatment and personal control were shown to be 
moderately related to one another but only personal control was related to diabetes 
coherence. Personal control scores had a weak negative correlation with PAID scores. 
Illness coherence was shown to have a moderate negative correlation with both PAID 
scores and weak negative correlation with A1c at baseline.   
Had primary variables been shown to be more strongly related to outcomes, 
whether in regression from indirect effects tests or with correlation statistics, it would 
have been informative to examine the primary variables within one comprehensive 
regression test. However, given the limited associations found, further supplemental 
analyses are focused on clarifying individual primary variable relationships with 
outcomes.   
Glucose control grouping. In order to compare differences between glucose 
control outcomes, subjects were grouped into three categories of glucose control (A1c) 
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based on ADA guidelines related to risk for disease complications (ADA, 2012). One 
group was comprised of those with A1c at baseline under 7% (n=21) as these are 
considered to be ‘adequately controlled’ and within a reasonable goal for glucose control 
for an individual with T2DM. The other group categories included a ‘borderline control’ 
group with individuals with an elevated risk of complications (under 9%; n=62) and ‘very 
poor control’ group with individuals at high risk for diabetes complications (9% or 
above; n=34). For these analyses, the outlier originally removed from A1c was reentered. 
Of the primary variables tested, only SMBG use for decision-making, tested using both 
nonparametric (Kruskal-Wallis) and parametric testing (ANOVA), was shown to 
significantly differ for each glucose control group [H(2)=9.796, p=.007; F(116)=5.50, 
p=.005]. Post hoc analyses for ANOVA (Scheffé) revealed a significant difference 
between the three grouping with the ‘adequately controlled’ group reporting significantly 
higher use of SMBG for decision-making than the ‘very poor control’ group  (p=.010) 
and the ‘borderline control’ group reporting significantly higher use than the ‘very poor 
control’ group (p=.040; see Figure 7). No significant differences were found between 
groups on diabetes belief scores (IPQ), diabetes distress (PAID) or SMBG adherence to 
provider recommendations (SDSCA).  
Diabetes distress and self-monitoring of blood glucose decision-making use. 
The relationship between SMBG decision-making and distress was further examined due 
to results from the testing of hypothesis 2. Non-parametric analysis (Kruskal-Wallis H-
test) was used to examine differences in reported diabetes distress (PAID) by SMBG 
decision-making group. PAID scores were found to significantly differ by SMBG 
decision-making group: H(4)=16.226, p=.003. Post hoc analyses (Tukey HSD) revealed a 
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significant difference between those responding ‘a moderate amount’ and ‘extremely’ 




























The purpose of the present study was to examine the use of the diabetes self-
management strategy self-monitoring of blood glucose (SMBG) from within a self-
regulatory theoretical framework. In this study, statistical analyses were used to examine 
the relationship between diabetes illness perceptions, SMBG behaviors, and diabetes 
wellness (diabetes distress and metabolic control) as components within a self-regulatory, 
common sense model of diabetes (Leventhal, 1970). Cross-sectional, self-report data of 
beliefs related to three components of illness perceptions (beliefs about the ability for 
treatment and personal actions to affect diabetes outcomes and the extent to which one 
feels diabetes makes sense to them) were examined for their connection to overall 
diabetes distress and overall glucose control. These relationships were considered within 
the context of the use of SMBG as a critical, self-regulatory, personal feedback tool. It 
was predicted that a higher frequency of using SMBG as a feedback tool, by way of 
increased use of this tool, would mediate the relationship between diabetes beliefs and 
these outcomes. 
The study was comprised of a sample of individuals with Type 2 diabetes who 
were prescribed injected insulin, or daily injected diabetes medication, who were 
receiving treatment at a specialty clinic located in a small, Midwestern town adjacent to a 
mid-sized city. Participants were adults, predominantly Caucasian, were generally highly 
educated, and had a range of socioeconomic and employment statuses.  
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Hypothesis Testing 
Hypothesis 1 (H1): Beliefs reflecting greater illness controllability will be 
indirectly associated with less diabetes distress (by way of both increased self-monitoring 
decision-making and higher frequency of testing).  
Hypothesis 1. The first step in the test of indirect effects test for hypothesis 1, the 
association between controllability beliefs and distress, was not supported. This 
relationship was predicted to be significant based on prior research that found 
associations between diabetes distress and other perceptions related to self-management. 
The lack of a significant regressive relationship between personal control and 
distress is surprising. Personal control, or the degree to which and individual feels that 
their personal actions have an impact on health outcomes, is generally thought to be a 
similar construct to diabetes-specific efficacy, which is consistently found to be related to 
distress (Robertson, Amspoker, Cully, Ross & Nail, 2013). The lack of support for this 
relationship may suggest that personal control beliefs are qualitatively different from 
diabetes efficacy beliefs. Examination of the phrasing of personal control items in the 
IPQ reveals that they are passively worded (e.g. “there is a lot which I can do to control 
my symptoms”) rather than actively worded (e.g. “I do a lot to control my symptoms”). It 
may be that personal control beliefs, as measured by the IPQ, represent a belief that 
control is possible, but without a consideration for one’s personal ability to act on this 
belief, as in self-efficacy. Diabetes self-efficacy was not measured in the present study; 
comparisons were not possible. 
A lack of a relationship between treatment control and distress may be due to 
conceptual concerns about the subscale. Beliefs about treatment control, or the degree to 
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which an individual feels that their recommended diabetes treatment regimens have an 
impact on health outcomes, had the most missing data of all primary variables. The single 
item missed or skipped by the most participants (n=4) on this subscale was ‘my treatment 
will be effective in curing my diabetes.’ There was a range of responses for this item with 
the modal response as ‘neither agree nor disagree.’ It may be that the use of the word 
‘cure’ in relation to diabetes was puzzling to respondents, leading them to skip the item. 
These respondents would not have been included in analyses. Interestingly, many 
responded that they “strongly” believed that treatment can cure their diabetes, a belief 
that could be considered to be inflated or unfounded as there is no known cure for T2DM 
once diagnosed. However, the implications of the “strongly” response depend on the 
reader’s interpretation of the word cure, which cannot be known given the questionnaire 
format. It may be that a strong belief in a diabetes cure combined with a lack of 
improvement in ones own condition could be disheartening and lead to difficulty coping 
and increased diabetes distress. Conversely, a strong belief in controllability through 
treatment may be related to less distress due to reduced concern for complications or 
one’s ability to manage T2DM. A bidirectional relationship such as this has the potential 
to mask any linear relationship between the two variables.  
It may also be that the relative homogeneity of the sample, as it relates to the 
construct of controllability, led to conceptual problems with comparing response 
differences. A weak, negative correlation was found between personal control beliefs and 
distress in supplemental analyses, suggesting that a sample with more varied beliefs 
related to their personal ability to control diabetes might have had a stronger relationship 
with overall distress. Personal control beliefs had a significant negative skew with most 
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reporting high perceived personal control. Similarly, treatment control beliefs were 
generally high in this sample. In essence, no respondents reported that they felt their 
actions, or the effect of their treatments, had no impact on their symptoms or diabetes 
management. Though a transformation was performed to reduce skew, the relative 
homogeneity of the sample in reported beliefs about controllability may have resulted in 
conceptual concerns that extend beyond problems with data normality. These concerns 
make it very challenging to understand, either conceptually or statistically, any existing 
relationship between these constructs. 
Hypothesis 2 (H2): Beliefs reflecting greater illness coherence will be indirectly 
associated with less diabetes distress (by way of both increased self-monitoring decision-
making and higher frequency of testing). 
Hypothesis 2. The first step in Hypothesis 2, that coherence is related to diabetes 
distress by way of decision-making use of SMBG, was not supported. However, greater 
perceived coherence, or understanding, of T2DM was related to less diabetes distress and 
this relationship was still significant when controlling for SMBG decision-making use. 
Instead of the hypothesized indirect effect, with SMBG decision-making mediating the 
relationship, the results suggest a possible indirect effect of beliefs between SMBG 
decision-making and distress. That is, an observed significant relationship between 
SMBG decision-making and diabetes distress was no longer significant when controlling 
for illness coherence. This relationship was further examined in supplemental analyses. A 
figural representation of diabetes distress (mean PAID scores) for responses related to the 
extent to which an individual is using SMBG for decision-making shows an interesting 
pattern (see figure 7). Average reported distress for individuals at varying levels of the 
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use of SMBG for decision-making appears to follow a curvilinear pattern with those 
falling in the middle of the SMBG decision-making range experiencing the greatest 
average distress. Mean distress scores for participants in the middle range fell above one 
standard deviation from mean for the whole sample indicating significant distress. Non-
parametric tests found the middle range group to significantly differ from those reporting 
their degree of SMBG decision-making use as “extremely.” Though responders in the 
lower SMBG decision-making groups (“not at all’ or “somewhat”) were not shown to 
significantly differ from others, this may be due to a loss of power with follow-up 
analysis, or the small group size of those using less frequently using SMBG for decision-
making. With increased sample size, it may be that the pattern appears more linear rather 
than curved. It may also be that participants reporting SMBG decision-making to a lesser 
degree are reporting lower diabetes distress due to the impact of another factor not 
considered in the present study, such as their perceptions about the importance of tight 
glucose control.  
Hypothesis 3 (H3): Beliefs reflecting greater illness controllability will be 
indirectly associated with lower hemoglobin A1c (by way of both higher decision-making 
and self-monitoring frequency).  
Hypothesis 3. The first step in the test of the indirect effects test for hypothesis 3, 
the association between controllability beliefs and glucose control, was not supported. 
This relationship was predicted to be significant based on prior research that found 
associations between control beliefs and glycemic control.  
The lack of a significant relationship between personal control and glycemic 
control is inconsistent with a body of prior research that has consistently found such an 
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association (McSharry et al., 2011). It also differs from what might be expected given 
prior research supporting a relationship between efficacy and glycemic control (Zulman 
et al., 2012) though, as mentioned previously, personal control beliefs as measured by the 
IPQ are likely measuring a construct distinct from diabetes self-efficacy.  
It is also interesting that treatment control was not related to actual glucose 
control. It was previously thought that treatment control has not been consistently 
supported in the literature, as relates to glycemic control, due to a lack of specification of 
treatment types (Mc Sharry et al., 2011), such as those using insulin and/or oral 
medications or diet alone; however, the present sample are all using insulin or daily 
injected diabetes medication, significantly minimizing this problem. It may be that the 
overall poor health of this sample, as evidenced by significant medical complications and 
poor glycemic control, makes testing associations with glycemic control difficult. Or, as 
mentioned previously, that an overall high belief in treatment controllability make 
associations difficult to observe.  
Another possible reason for a lack of relationship between treatment control and 
glucose control is that some individuals have changes in their treatment control beliefs 
across time, which are impacted by not perceiving improvement in glucose control. 
Insulin treatment in T2DM is generally seen as a last resort for management of glucose 
levels when oral medications or diet alone have not been effective. As observed in this 
sample, when someone has been on insulin for a longer period of time, they are less 
likely to believe in the ability of treatments, in this case insulin, to control their diabetes. 
Therefore, for some individuals, a higher glucose level may be related to lower treatment 
beliefs while for others it is related to higher treatment beliefs.   
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Hypothesis 4 (H4): Beliefs reflecting greater illness coherence will be indirectly 
associated with lower hemoglobin A1c (by way of both higher decision-making and self-
monitoring frequency).     
Hypothesis 4. The first step in the test of indirect effects test for hypotheses 4, the 
association between diabetes coherence and glucose control, was not supported. There is 
limited prior research on diabetes coherence and outcomes. The hypothesis was based on 
prior research consistently finding associations between general diabetes knowledge and 
glucose control. Coherence was found to be related to glucose control via basic 
correlation. It is possible the relationship between these variables is complex and there 
was not sufficient power in the present study to support a regressive relationship.  
Support for the Self-Regulation Model for SMBG 
Though there is extensive prior research on SMBG behaviors in the T2DM 
population, little prior research has yet to systematically examine the use of SMBG for 
decision-making as it relates to diabetes outcomes, and no known studies have examined 
its use from within a theoretical framework. Much of the prior SMBG research has been 
frequency driven. The present study sought to further the current state of knowledge 
about SMBG behaviors by drawing from the broader health psychology literature on the 
psychological processes that explain self-management choices. 
Due to the lack of prior, theoretically-based SMBG research, only select portions 
of the Self-Regulation Model (SRM) were examined, in an exploratory fashion. Specific 
illness perceptions, those related to controllability and coherence, were examined 
individually. Controllability has some prior support as it relates to overall diabetes care 
and coherence with no prior studies related to SMBG decision-making. Coherence has 
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not yet been examined as it relates to SMBG.  
  In the present study, the planned methods used to test the self-regulation model 
for SMBG did not yield significant results. As such, results are inconclusive related to the 
usefulness of the Self-Regulation, Common Sense, Model of illness beliefs as it relates to 
the use of SMBG for diabetes management. However, findings point to a broader 
possibility that the Self-Regulation Model may still be an appropriate way to 
conceptualize SMBG use. For example, a finding from supplemental analyses indicated 
that A1c was not associated with SMBG adherence, but was associated with SMBG 
decision-making. This supports the idea that use as a decision-making strategy may be 
critically distinct from simply examining SMBG frequency adherence in glucose control 
efforts, which has implications for both clinical practice targets and future research. 
Additionally, diabetes coherence was shown to be related to diabetes distress with some 
effect on decision-making. It may be that improvements in glucose control efforts by way 
of increased decision-making use of SMBG depend on the degree of illness coherence 
perceived by the individual. Further research is needed to examine the nature of the 
relationships between illness beliefs, SMBG behaviors and diabetes outcomes.  
A number of aspects of the study characteristics may have influenced the nature 
of the participant sample and, in turn, characteristics of the sample may have influenced 
the observed study findings. These issues are discussed below.  
Study characteristics influencing participation. The appointment format 
structure for blood draws at the JDC made it difficult for research staff to be present at 
the clinic at the time that each eligible patient presented for their blood draw. At the JDC, 
blood draw appointments are scheduled for a given date, but may occur as a ‘drop-in’ 
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within a time window of several hours. In addition, because the screenings were 
completed prior to JDC appointment reminder calls, in some cases, patients were 
rescheduled which resulted in them presenting for their blood draws on different days 
than those anticipated by the research study personnel.   
The point of recruitment proved difficult for research staff with a high number of 
eligible patients declining to participate due to a lack of time. Several, particularly those 
presenting to the clinic very early in the morning (e.g. 7:00 am), planned to go directly to 
work after their appointment and were unable to spare the time to discuss consenting. In 
addition, most patients are required to be fasting for blood draw appointments and were 
hungry; taking the time to review study details and consent procedures may have been 
deemed too uncomfortable or difficult, leading many to decline. 
Completion rates were similar to a previous JDC study; however, rates were 
lower than expected due to the added lottery incentive. Approximately one quarter of 
participants did not return the questionnaire. Return rates appeared to improve when each 
participant was provided with a stamped return envelope at the point of consent, rather 
than having it offered as optional. It is likely that a number of participants forgot to bring 
their questionnaires to their provider appointment and did not wish to return the 
questionnaire to the JDC at a later date. Of those who completed questionnaires, missing 
data was around 20%, as predicted.  
Revocations were rare (4.3%) and several appeared to be accidental. Some 
participants returned the revocation form in the same packet as the completed 
questionnaire. Others noted as their reason for revocation that they did  “not have time,” 
despite having completed all necessary actions, suggesting that they were referring to a 
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follow-up study that was described during consent. A small number, due to screening 
error, were found to be ineligible at the point of medical chart data review.  
Participant characteristics with potential influence on outcomes 
High disease comorbidity. Most participants had glucose control levels (A1c) that 
fell above the ADA recommended target for glucose control. A1c levels above this target 
represent a higher likelihood of experiencing cardiovascular and other diabetes-related 
complications and morbidity. In addition, the sample had a mean BMI in the obese range 
and was within one standard deviation of morbid obesity—a health marker that is also 
highly related to significant medical comorbidity. Not surprisingly, the sample had a high 
number of comorbid medical diagnoses in their medical charts; the most common of 
these were hyperlipidemia, hypertension, and peripheral neuropathy. Given the high 
comorbidity rate, the participant sample from this study is less likely to see quick 
progress with A1c improvements when compared with other T2DM participant samples. 
As such, these participants may have different perceptions of treatment efficacy in their 
diabetes management efforts.  
High burden of care. Chart-extracted provider diabetes self-care 
recommendations for the sample were generally intensive. The modal prescribed times 
per day of injecting insulin was 4 with modal SMBG recommendations of 3-4 times per 
day. This translates to a large portion of the sample having recommendations to use a 
needle for either testing or injecting around 8 times per day. In addition, many 
participants had a high number of medications prescribed, including diabetes oral 
medications (around 75%), further contributing a high self-care burden.  
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Time since diagnosis. There was a large range of experience with T2DM and 
insulin with some as recently diagnosed 2 years ago and others having a T2DM diagnosis 
for over 40 years. Mean insulin prescription onset occurred about 6 years prior to the 
study. Both variables have missing data due to no record of the information in existing 
medical charts. This was most often the case for patients with electronic medical records, 
as old medical records were not always uploaded to the electronic system (around one 
third of patients). As such, associations between variables should be interpreted with 
caution.   
High overall compliance in multiple self-management domains. Due to the 
impact of health behaviors on glucose management, such as dietary and physical activity 
behaviors, T2DM self-care recommendations generally fall in a number of health 
domains (ADA, 2012). In this study, these other health domains were measured by 
responses on a self-report measure of days engaging in recommended self-care activities 
during the week prior. A number of associations were found between primary study 
variables and dietary behaviors, such as following a healthful eating plan and spacing 
carbohydrates throughout the day, but there were fewer associations with exercise 
behaviors and medication behaviors. This may be due to the non-normally distributed 
data from these variables that is difficult to interpret. Only around 15% of respondents 
reported that they did not take their recommended diabetes medication on at least one day 
during the last week. Similarly, only 24% reported not taking insulin as recommended 
every day. These responses reflect a sample with high overall compliance, limiting 
interpretive possibilities. Non-parametric tests revealed some associations in the skewed 
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variables, though these should be interpreted with caution. For example, those reporting 
higher illness coherence were more likely to take insulin injections as recommended.  
Overall low physical activity.  Responses on exercise behavior items reflected 
unusually low compliance. The modal response for both items, which were related to 
general levels of activity and planned exercise, was 0 days per week. While this sample 
appears to be highly compliant with medication recommendations, they also appear to be 
largely sedentary. This may be partly related to the older mean age of the sample or the 
high rate of physiological comorbidity, and is reflected in the sample’s high mean BMI. 
Exercise is considered by the medical community to be a means for improved glucose 
control through both direct and indirect pathways. Directly, aerobic activity improves the 
body’s ability to process glucose. Indirectly, resultant weight loss can decrease burden on 
endocrine system function, thus, improve glucose processing. The pattern of responding 
in this sample highlights the complexity of adherence to recommendations for these 
participants. That is, health decisions related to one domain of care are not necessarily 
indicative of health decisions in other domains. Self-regulatory processes may greatly 
differ between self-care domains based on beliefs about the importance of these 
behaviors in controlling diabetes, or other, external barriers such as pain. 
Diet behaviors varied. Participants showed greater variability on responses 
related to diet plans. These variables were associated with many primary items 
suggesting that diet behaviors are more open to the influences of perceptions and 
decision-making than other self-care behaviors. Interestingly, following a healthful eating 
plan, while associated with all other primary variables, was not associated with treatment 
control beliefs. It is possible that a healthful eating plan is not viewed as a medical 
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treatment, though diet is used to treat T2DM, but rather a self-care mechanism of 
personal action. This has important implications for understanding overall perceptions of 
T2DM management self-care activities.  
Mental health. While it would be interesting to examine illness perceptions and 
behaviors as they relate to psychological comorbidities, only a small number of 
participants were found to be diagnosed with a mood or anxiety disorder via a review of 
medical chart data. This number likely greatly underestimates the existence of mental 
health diagnoses in the present sample. Recent estimates of clinical depression rates in 
individuals with T2DM are around two times greater than that of the non-T2DM 
population (Gonzalez et al., 2007), which is thought to be due to both physiological 
factors and self-care burden (Renn et al., 2011). The low number of noted psychological 
diagnosis in this sample is possibly due to the nature of the JDC. Specifically, the JDC 
keeps their own medical records separate from other clinics for the approximately 2/3 of 
patients who have paper medical charts, and there is an absence of a mental health 
practitioner within the clinic setting. Mental health diagnoses were likely only noted in 
the chart if the participant were prescribed psychotropic medications or if the patient 
brought records from another facility where they were evaluated for psychological 
conditions. As such, some participants may have an undiagnosed mental health disorder.  
Nearly 30% of participants were found to be prescribed an antidepressant 
medication. Unfortunately, antidepressant prescription cannot serve as a proxy for mental 
health diagnosis in T2DM, as medications from this class (e.g. gabapentin, pregabalin, 
topiramate, tegretol) are frequently prescribed as an effective method for the management 
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of nerve pain, such as the pain associated with peripheral neuropathy, a common 
complication of T2DM.   
Decision-Making as a Critical Distinction in SMBG Behavior 
To date, very little research has considered decision-making separately from other 
SMBG behaviors. Earlier studies have supported a relationship between greater 
knowledge about strategies for glucose management and better control (Brega et al., 
2012; Zulman et al., 2012) but these were not specific to SMBG. The present study is 
unique in considering decision-making separately, as a specific strategy among a set of 
other SMBG behaviors that are more typically studied. Though all SMBG behaviors were 
shown to be moderately interrelated via correlation statistics, their associations with other 
primary variables differed. This suggests that these differing behaviors may correspond to 
distinct concepts. For example, SMBG frequency of adherence to daily provider 
recommendations was associated with beliefs about treatment control only, and not with 
personal control or coherence beliefs. For SMBG decision-making the opposite was true. 
Given these associations, it is possible that SMBG adherence behaviors are related to 
specific beliefs about the helpfulness of medical intervention, while SMBG decision-
making reflects a more complex system of beliefs and behaviors about engaging in what 
makes sense to an individual given their personal ability to affect outcomes.   
Interestingly, in this sample, SMBG adherence was not related to actual glucose 
control and SMBG decision-making was, though both SMBG behaviors were negatively 
associated with problems coping with diabetes (PAID). This suggests that decision-
making represents a construct with more direct influence on outcomes, and is therefore an 
important consideration in the self-management practices of individuals with T2DM. 
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Indeed, national recommendations for diabetes management have been updated since the 
beginning of the present study to address the importance of this practice in 
recommendations for SMBG. However, due to limited research, the evidence for these 
changes was classified as based on “expert consensus” (ADA, 2013, pg s17).  
Coherence is Key 
Illness coherence perceptions, or the extent to which individuals feel they 
understand their T2DM, were more varied than controllability beliefs. Though the sample 
was generally supportive of management practices as important, very few (about 12%) 
responded in a way that indicated they had no uncertainty about, or difficulty 
understanding, their T2DM. That many feel they do not understand their T2DM is 
particularly interesting given the relative lack of prior research regarding this construct. It 
was previously thought that coherence would be lower in individuals newly diagnosed 
with T2DM or who have not completed diabetes education but improves with education. 
In this study, completed within a specialty clinic where nearly all participants have 
already completed some degree of diabetes education, coherence was not associated with 
time since T2DM diagnosis or time since insulin prescription. The large range in 
coherence beliefs in a generally treatment-compliant, experienced T2DM population 
might dispose coherence to be an illness belief particularly open to intervention. For 
many, there is room for improvement in coherence while other factors appear to have 
been targeted in either diabetes education, provider contacts, or both as evidenced by 
high overall controllability beliefs. In this sample, greater coherence was associated with 
a higher level of education completed and higher socioeconomic status. As coherence 
was also associated with less distress and better glucose control, education level may be 
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an important consideration for tailoring interventions targeted improving self-care 
decision-making through T2DM coherence.  
Distress is Not Related to Glucose Control 
Participants reported a range of diabetes distress with some endorsing little to no 
difficulty and others endorsing very frequent problems with things such as worrying 
about complications and feeling overwhelmed, angry, alone, deprived, or unsupported in 
their diabetes management efforts. Many individuals reported some level of distress, 
which is not surprising given the high burden of treatment with insulin prescriptions and 
the numerous recommended self-care behaviors in other areas of their life. The degree of 
distress in this sample was relatively matched to a normative sample of individuals with 
T2DM also on insulin treatment. Those with less distress were generally younger, with 
high personal control beliefs and high coherence beliefs and were generally using SMBG 
for decision-making. 
 There is limited prior research related to the relationship between diabetes 
distress and SMBG decision-making. Though none of the hypothesized relationships 
were supported, distress was found to be negatively related to illness beliefs and SMBG 
behaviors, including decision-making, through basic correlation. Additionally, distress 
was not shown to be related to overall glucose control through basic correlation.  
In the present study, participants completed self-report measures, including items 
related to diabetes distress, before receiving their A1c results. This allowed for the 
sample’s perceptions of control to depend exclusively on their SMBG results. Diabetes 
distress was not shown to be directly related to A1c. Though the lack of a relationship 
may be, in part, due to not being aware of their results, those engaging in SMBG 
  
	   76 
generally have an estimate of their control based on SMBG results. The lack of a 
relationship between distress and glucose control highlights that effective coping related 
to diabetes may depend more heavily on extraneous factors.  
Treatment Control Beliefs and Time Since Diagnosis 
Treatment control beliefs were found to be negatively correlated with time since 
insulin prescription, suggesting that those who have been on insulin longer are less likely 
to think that treatment measures can significantly help to manage or their T2DM. This 
might be reflective of an individual who has been on insulin for a long time with very 
limited improvements in their glucose control. Indeed, prior research has pointed to a 
possible deterioration in treatment control beliefs when patients made lifestyle changes, 
such as beginning insulin treatment based on provider recommendations but not 
observing improvements in their condition, leading to lower adherence to 
recommendations in the future (Lawton et al., 2008; as cited in Gomersall et al., 2010).  
Personal Control and Treatment Control Beliefs Differ 
Association with other variables, such as diet behaviors, differ between personal 
and treatment control beliefs, suggesting that participants view some self-care behaviors, 
such as diet, in a personal control category and others, such as medications, as a medical 
treatment. Interestingly, a relationship to SMBG decision-making was generally seen to 
exist across both categories. SMBG is, perhaps, seen as both a tool to aid personal control 
and also aid treatment. These views may also differ by the individual.  
Treatment control was associated with fewer reported problems related to diabetes 
distress, greater belief that personal behaviors impact diabetes outcomes, and greater 
adherence to provider SMBG and diabetes oral medication recommendations. 
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In this sample, both treatment and personal control beliefs were not associated with 
glucose control outcomes, suggesting that illness beliefs alone do not explain why some 
individuals are more successful at managing their diabetes than others.  
Other items on the treatment control beliefs measures are worded in a very 
general manner. For example, one item asks the participant to identify how strongly they 
feel that “there is nothing that can be done to control my diabetes” without specifying a 
treatment type, such as medications or insulin. It may be difficult to interpret what is 
measured by this subscale as it relates to the T2DM population on insulin.  
Strengths and Limitations  
 Strengths of the Present Study  
Contribution to limited literature. The present study represents a significant 
contribution to the current body of literature on diabetes self-management; there is little 
prior research examining SMBG that considers whether or not the individual is using 
their result to inform health behaviors. This is despite a recent adjustment to medical 
guidelines from a major national organization (ADA) reflecting the importance of this 
construct. Current research on SMBG decision-making is very limited and no known 
studies have been designed with a theoretical framework for understanding for this 
relationship. Without an understanding of the mechanism through which this activity 
improves control, informed strategies to improve SMBG practices in individuals with 
poor control will be limited.  
Within the context of limited research on SMBG decision-making the relationship 
between diabetes distress and SMBG decision-making has been particularly overlooked. 
The present study represents a significant contribution to the literature in its consideration 
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of diabetes distress as an important factor in understanding the complex psychological 
processes involved in the use of SMBG in this manner.  
Mixed data sources. The present study utilized both medical chart data and self-
report information. Often, studies examining perceptions do not have the support of 
medical chart data. The collective use of both self-report and medical chart data allows a 
more comprehensive analysis of participant health status and medical care 
recommendations and reduces bias due to self-reporting.  
 The sample is prescribed insulin. Prior research examining diabetes perceptions 
in the T2DM population rarely exclusively examine an insulin-using population. The 
inclusion criteria requiring an insulin prescription, or other daily injected diabetes 
medication, ensures that all participants share a similar degree of burden that is typically 
much higher than those not prescribed an insulin regimen. Indeed, the typical participant 
in the present study is recommended to use insulin and SMBG around 4 times per day for 
each activity in addition to the comprehensive self-care regimen related to many other 
areas of their daily life. This high degree of burden makes the use of self-regulatory 
strategies particularly relevant for all participants in the study.   
The sample is free from recent clinic setting feedback. The decision to arrange 
the study such that completion of the questionnaire packet took place before a provider 
visit allowed the perceptions reported in the questionnaires by participants to be based 
almost entirely on feedback experienced outside of the clinic setting, such as from SMBG 
or self-perceived symptoms. This ensured that participant perceptions related to the 
illness regulation process, as they have occurred over the past several weeks, were due to 
self guided actions rather than medically guided actions. In addition, glucose control 
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averages for the weeks prior to the appointment, likely the same time period on which the 
participant based their responses, were collected within the same week that the 
questionnaires were completed. This provided a physiological indicator of actual glucose 
control to be used in the study as an outcome with the reported perceptions of glucose 
control occurring prior to the participant being aware of this result. It is difficult in any 
illness requiring intensive medical intervention to capture patient perceptions without 
recent influence of provider feedback, particularly when recruitment for studies typically 
occurs at the point of the provider visit.    
Limitations of the Present Study 
Cross-sectional design. A primary limitation of the present study is the cross-
sectional study design. The basic indirect effects model used in this study (Baron & 
Kenny, 1986) has been criticized for considering indirect effects, referred to as statistical 
mediation, to be analogous to the construct of mediation, which in theory requires 
temporal data. One way to remedy this would be to conduct a longitudinal study that 
follows glucose control over time. This may be problematic for glucose control, however, 
as change in A1c is likely to be minimal for those already exhibiting control close to 
recommended levels. For the present study, indirect effect findings should be considered 
correlational.  
Homogenous sample. Another limitation in this study is the relative homogeneity 
of the sample. The sample is all from a specialty clinic, nearly all had had some amount 
of formal diabetes education and most are testing at least daily. From a conceptual 
standpoint, insulin users who chose to attend a specialty clinic may be different from 
community settings of poorly controlled Type 2 DM. Indeed, this is reflected in 
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participant responses related not only to high adherence to SMBG recommended 
frequency but also in that most reported that they believed personal behaviors played a 
large role in the outcomes from their diabetes. The limited range in these constructs may 
have reduced the impact of these and other constructs examined in the study.  
It is possible that the greater number of significant relationships between 
coherence and other primary constructs is due to the comparatively greater range of 
beliefs related to illness coherence in this sample. With a more varied range of beliefs, it 
is easier to measure differences in other constructs as they relate to the belief. It may be 
that with a sample with more varied controllability beliefs, such as may be found in a 
community-based or primary care clinic, relationships will be more easily examined.    
Measurement of SMBG. One of the most critical data limitations in this study is 
the type of measure available to examine SMBG behaviors, including SMBG decision-
making. Decision-making was measured with a single likert-type item, leading to 
challenges identifying appropriate testing procedures and significant difficulty 
interpreting results. Unfortunately, given the lack of prior research related to this 
construct, there is not currently a validated measure of SMBG decision-making available 
to use.  
Additionally, the measure used for other SMBG behaviors, the SDSCA, was 
problematic. Though the SDSCA is generally considered a gold-standard for measuring 
SMBG and other self-care activities in T2DM, the unique subset in this study, those 
prescribed insulin therapies, have SMBG frequency recommendations that greatly exceed 
general recommendations. The difference in frequency recommendations led to the 
problematic ceiling effect that was observed in our sample and rendered the use of the 
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SMBG frequency variable in the original planned analyses to be highly problematic. 
None of the hypothesized relationships between illness beliefs, SMBG decision-making 
behaviors and diabetes distress or glucose control were fully statistically supported. It 
may be that the loss of power due to excluding participants who report testing less than 5 
days per week impacted the likelihood of finding a significant result.  
Implications and Recommendations  
Clinical implications and recommendations. Further research is needed before 
clear clinical implications can be drawn. Much of the research related to SMBG is 
atheoretical and no known studies examining SMBG decision-making are based on a 
conceptual framework from which to inform clinical practice. Without an understanding 
of the mechanism through which decision-making improves control, recommendations 
for strategies to improve SMBG practices in individuals with poor control are limited.  
However, there are a number of patterns observed in the present, exploratory 
study that may help to shape the direction of future clinical intervention and examination. 
Results from the present study point to possible clinical targets such as illness coherence 
and diabetes distress. Findings suggest that illness coherence may support the use of 
SMBG for decision-making. This has implications for interventions targeted at improving 
coping with diabetes demands. Coherence was found to differ by education level and SES 
and greatly vary in an otherwise relatively homogenous sample. If supported in future 
studies, providing diabetes coherence-specific education for individuals with low 
education could facilitate improvements in perceived distress and the possible impact of 
distress on health outcomes. Alternatively, providing supportive materials to support 
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coherence needs, such as tables or decision-trees may prove helpful in reducing distress 
or improving glucose control.   
Research implications and recommendations 
Measurement of SMBG. Significant statistical and conceptual interpretation 
difficulty resulted from problems with SMBG variables in this study. Results suggest that 
the SDSCA may not be an appropriate measure of SMBG frequency in an insulin treated 
population. Current recommendations for intensive insulin users are to SMBG at least 
with every meal or insulin administration  (ADA, 2013). The current study’s participants 
were considered to be generally highly compliant due to most reporting at least daily 
SMBG; however, in line with medical guidelines, SMBG recommendations were 
generally multiple times per day. Due to the response options on the SDSCA, an 
individual reporting that they engaged in SMBG 7 times in the last week has the same 
response selection as an individual who SMBG 28 times in the last week. Though it may 
be that only the latter participant is strictly adhering to their provider’s recommendations, 
this is not clear from the measure. Importantly, more robust and validated measures are 
needed to effectively examine SMBG decision-making. A single, likert-type item is 
difficult to examine both conceptually and statistically. Valid, reliable measures are 
needed to support future research related to this construct. 
Alternative Methods. Distress was negatively related to both SMBG behaviors 
and illness beliefs in the present study. Due to the exploratory nature of the present study, 
distress was generally considered as an outcome; however, within the self-regulatory 
framework, distress could be understood as coping, which may act as a potential 
moderator between beliefs, behaviors and glucose control outcomes. Future studies could 
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examine this potential relationship, ideally with a measure of depression included to 
control for the effects of broad depressive symptoms.  
Sample. Homogeneity of the present sample, though a strength in many ways, 
made interpretation of results, such as those related to controllability beliefs, difficult to 
interpret. This was largely due to the ceiling and flooring effects from the measures 
selected for this study. Future studies of insulin-treated T2DM should consider utilizing 
different measures with expanded options to better assess for differences in this 
population. Alternatively, examining these relationships in a less homogeneous sample, 
such as a community outpatient clinic, would potentially provide a greater range of 
controllability beliefs. This, too, would be helpful in clarifying this construct as it relates 
to other components within a self-regulatory process.  
 Summary of conclusions 
 The present study examined SMBG as part of a self-regulatory process of health 
decision-making that involves a complex interaction of feedback, illness perceptions, and 
distress. Findings suggest that illness perceptions play an important role in the process of 
SMBG use for decision-making as it relates to glucose control and diabetes distress in 
insulin-treated T2DM. There are no other known studies that have examined SMBG use 
as a decision-making tool from a theoretical perspective. Though the study was cross-
sectional and largely exploratory, the study consists of both self-report and medical chart 
data with temporal control for feedback about overall glucose control making this a 
strong contribution to the current literature and providing a solid empirical foundation for 





Table 1. Statistical procedures for testing hypotheses with the Joint Significance Test 
*SMBGdm = self-monitoring of blood glucose decision-making; SMBGf = self-monitoring of blood 
glucose frequency; Controllability = the controllability subscale of the IPQ-R; Coherence = the 
coherence subscale of the IPQ-R; PAIDt = total score on the Problem Areas in Diabetes Scale; HbA1c 
= hemoglobin A1c 
**bx is the beta weight of a given test of regression, sbx is the standard error of the regression  
Hypothesis 1 (H1):  
The following statistical hypotheses will be tested 
 
(1) SMBGdm  = β01 + β1 (controllability) + ε1 
(2) SMBGf  = β02 + β2 (SMBGdm) + β3 (controllability) + ε2 
(3) PAIDt = β03 + β4 (controllability) + β5 (SMBGf) + β6 (SMBGdm) + ε3 
 
Hypothesis 2 (H2):  
The following statistical hypotheses will be tested 
 
(1) SMBGdm  = β01 + β1 (controllability) + ε1 
(2) SMBGf  = β02 + β2 (SMBGdm) + β3 (controllability) + ε2 
(3) HbA1c = β03 + β4 (controllability) + β5 (SMBGf) + β6 (SMBGdm) + ε3 
 
Hypothesis 3 (H3):  
The following statistical hypotheses will be tested 
 
(1) SMBGdm  = β01 + β1 (coherence) + ε1 
(2) SMBGf  = β02 + β2 (SMBGdm) + β3 (coherence) + ε2 
(3) PAIDt = β03 + β4 (coherence) + β5 (SMBGf) + β6 (SMBGdm) + ε3 
 
Hypothesis 4 (H4):  
The following statistical hypotheses will be tested 
 
(1) SMBGdm  = β01 + β1 (coherence) + ε1 
(2) SMBGf  = β02 + β2 (SMBGdm) + β3 (coherence) + ε2 
(3) HbA1c = β03 + β4 (coherence) + β5 (SMBGf) + β6 (SMBGdm) + ε3 
 
Path for rejecting the null hypothesis in joint significance test:  
Reject if:  
(4)   (|b1|/sb1) > t.975(n-2)  
and… (5)   (|b2|/sb2) > t.975(n-3)   
and… (6)   (|b3|/sb3) > t.975(n-4)   
 
	   85 
	  
	   86 
	  
	   87 
	  	  	  
	   88 
	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   89 
	  	  	  	  	  
	   90 
	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   91 
	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   92 
	  	  	  	  	  	  
	   93 
	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   94 
	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   95 
	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   96 
	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   97 
	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   98 
	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   99 
	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   100 
	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   101 






























Figure 1. The Self-Regulation Model and Illness Behavior (adapted from Elwy et al, 2011). This figure represents to basic 









































Figure 2. Path diagram of the three-path mediated effect model (adapted from Taylor 
et al., 2008).  
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Figure 4. Path diagram of revised simple mediation model (Baron & Kenny, 1986).  
The effect of X on Y is hypothesized to have an indirect effect on M (c’ represents the 
direct effect). 
              X 
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Figure 5. Participant flow diagram of recruitment and retention numbers.  
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Figure 6. Path diagram of revised simple mediation model in reverse order (Baron & 
Kenny, 1986).  The effect of X on Y is hypothesized to have an indirect effect on M (c’ 
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Figure 7. Mean SMBG decision-making use by glucose control group. 
 
 
a p-values are from Tukey HSD post hoc analyses comparing means ranks for response on  
SMBG decision-making item, H(2)=9.796, p=.007 
b difference between “well controlled” and “very poor control” group (p=.007)  
c difference between “borderline” group and “very poor control” (p=.030) 	  
b	  p=.007**	  	  c	  p=.030*	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Figure 8. Mean diabetes distress score by self-monitoring of blood glucose 
decision-making group. P-­‐value	  indicates	  a	  significant	  difference	  in	  post	  hoc	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Appendix 1 Guide to Abbreviations  
 
 
A1c: Abbreviation of Hemoglobin A1c, a physiological marker of long-term 
blood glucose control, currently the standard marker in Diabetes 
diagnosis and disease progression 
ADA: American Diabetes Association 
CSM: Common Sense Model (illness representation component of the Self-
Regulation Model) 
HCP:   Healthcare provider 
IDF: International Diabetes Federation  
JDC:   Joslin Diabetes Center 
SMBG: Self-monitoring of blood glucose 
SRM: Self-regulation model (of illness behavior) 
T1DM:  Type 1 Diabetes Mellitus, previously referred to as insulin dependent    
Diabetes Mellitus (IDDM) 
T2DM:  Type 2 Diabetes Mellitus, previously referred to non-insulin dependent 
Diabetes Mellitus (NIDDM) 
 
 




Questionnaire Packet  
 
GENERAL BACKGROUND INFORMATION 
 
1. Today's date: ___________________ (month/day/year) 
  
2. How old are you?  _____________________ (years old) 
 
3.         Gender 
  
 Female   Male 
 
4. How tall are you?     
 
 ___  feet    __ __  inches 
 
5. How much do you currently weigh?   
 
 __ __ __  pounds 
 
6. Ethnic group (check one box): 
 1 White (non-Hispanic)   4 Asian 
 2 Black     5 Other Specify Below 
 3 Hispanic     (____________________)
  
 
7. Marital status (check one box): 
   1   Never married     4   Divorced 
 2   Currently married    5   Widowed 
    3   Separated 
 
8. Current living arrangement (check one box): 
 1   Live alone       5   Live with roommate            
                    who is not partner 
 2   Live with spouse/partner        6   Live with parents 
 3   Live with spouse/partner and children  7   Other 
 4   Live with children (no spouse/partner)     
 
9. Level of school completed (check one box): 
 1   Less than 7th grade     5   Partial college  
      or specialized training 
 2   Junior High School (7th, 8th, & 9th grade)  6   College or  
        university graduate 
 3   Partial high school    7   Graduate  
        (10th or 11th grade)   professional training  
 4   High School graduate (Includes G.E.D.)     (graduate degree) 
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10. Approximate annual gross income for your household:  (check one number)  
(Remember all information you provide will remain completely confidential) 
            1    Less than $ 10,000  4   $40,000 - $59,999  
            2    $10,000 - $19,999  5   $60,000 - $100,000 
            3    $20,000 - $ 39,999  6   Greater than $100,000 
 
11. Which category best describes your usual occupation?  If you are not currently 
employed, which category best describes your LAST job?  (check one number) 
 1 Professional (e.g., teachers/professors, nurses, lawyers, physicians, & 
engineers) 
 2 Manager/Administrator (e.g., sales managers) 
 3 Clerical (e.g., secretaries, clerks or mail carriers) 
 4 Sales (e.g., sales persons, agents & brokers) 
 5 Service (e.g., police, cooks, waitress, or hairdressers) 
 6 Skilled Crafts, Repairer (e.g., carpenters) 
 7 Equipment or Vehicle Operator (e.g., truck drivers) 
 8 Laborer (e.g., maintenance factory workers) 
 9 Farmer (e.g., owners, managers, operators or tenants) 
10 Member of the military 
11 Homemaker (with no job outside the home) 
12 Other (please describe)_______________________________________ 
__________ 
 
12. Current employment situation (check all that apply): 
    1  Full time at job 
    2  Part time at job 
   3   On leave with pay 
    4   On leave without pay 
                          5    Disabled 
    6    Seeking work 
    7    Retired 
     8    Homemaker 
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YOUR VIEWS ABOUT YOUR DIABETES (IPQ-R) 
 
Listed below are a number of symptoms that you may or may not have 
experienced since your diabetes. Please indicate by circling Yes or No, 
whether you have experienced any of these symptoms since your 
diabetes, and whether you believe that these symptoms are related to 
your diabetes. 
 
  I have experienced 
this symptom 
since my diabetes 
 This symptom is 
related to my 
diabetes  
 
      
Pain   Yes No Yes  No 
      
Sore Throat  Yes No Yes No 
      
Nausea  Yes No Yes No 
      
Breathlessness  Yes No Yes No 
      
Weight Loss  Yes No Yes No 
      
Fatigue  Yes No Yes No 
      
Stiff Joints  Yes No Yes No 
      
Sore Eyes  Yes No Yes No 
      
Wheeziness  Yes No Yes No 
      
Headaches  Yes No Yes No 
      
Upset Stomach  Yes No Yes No 
      
Sleep Difficulties  Yes No Yes No 
      
Dizziness  Yes No Yes No 
      
Loss of Strength   Yes No Yes No 
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We are interested in your own personal views of how you now see your current diabetes. 
 
Please indicate how much you agree or disagree with the following statements about our 
diabetes by checking the appropriate box. 
 




1 This diabetes will pass quickly 
 
     
2 I expect to have this diabetes for the 
rest of my life 
 
     
3 My diabetes is a serious condition 
 
     
4 My diabetes has major consequences 
on my life 
 
     
5 My diabetes does not have much 
effect on my life 
 
     
6 My diabetes strongly affect the way 
others see me 
 
     
7 Me diabetes has serious financial 
consequences 
 
     
8 My diabetes causes difficulties for 
those who are close to me 
 
     
9 There is a lot which I can do to control 
my symptoms 
 
     
10 What I do can determine whether my 
diabetes gets worse 
 
     
11 The course of my diabetes depends 
on me 
 
     
12 Nothing I do will affect my diabetes 
 
     
13 I have the power to influence my 
diabetes 
 
     
14 My actions will have no affect on the 
outcome of my diabetes 
 
     
15 My diabetes will improve in time 
 
     
16 There is very little that can be done to 
improve my diabetes 
 
     
17 My treatment will be effective in 
curing my diabetes 
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18 The negative effects of my diabetes 
can be prevented (avoided) by my 
treatment 
 
     
19 My treatment can control my diabetes 
 
     
20 There is nothing which can help my 
condition 
 
     
21 The symptoms of my condition are 
puzzling to me 
 
     
22 My diabetes is a mystery to me 
 
     
23 I don’t understand my diabetes 
 
     
24 My diabetes doesn’t make any sense 
to me 
 
     
25 I have a clear picture or 
understanding of my condition 
 
     
26 The symptoms of my diabetes change 
a great deal from day to day  
 
     
27 My symptoms come and go in cycles 
 
     
28 My diabetes is very unpredictable 
 
     
29 I go through cycles in which my 
diabetes gets better and worse 
 
     
30 I get depressed when I think about my 
diabetes 
 
     
31 When I think about my diabetes I get 
upset 
 
     
32 My diabetes makes me feel angry 
 
     
33 My diabetes does not worry me 
 
     
34 Having this diabetes makes me feel 
anxious 
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BLOOD SUGAR TESTING 
 
1.  To what extent are you using your blood sugar testing to decide what to do, like what 
to eat or how to be physically active, to manage your diabetes? 
  
     0                      1                       2                       3                            4                    





The two questions below ask you about your diabetes self-care during the last 7 days. If 
you were sick during the past 7 days, please think back to the last 7 days that you were not 
sick. 
 
2. On how many days of the last SEVEN DAYS did you test your blood sugar? 
 
0 1 2 3 4 5 6 7 
 
3. On how many of the last SEVEN DAYS did you test your blood sugar the number of times 
recommended by your health care provider? 
 
0 1 2 3 4 5 6 7 
 
 
Problem Areas In Diabetes (PAID) Questionnaire 
 
INSTRUCTIONS: Which of the following diabetes issues are currently a problem for you? 
Circle the number that gives the best answer for you.  











1. Worrying about the future and the 
possibility of serious complications. 
 
    
2. Feeling guilty or anxious when you 
get off track with your diabetes 
management. 
 
    
3. Feeling scared when you think 
about living with diabetes. 
 
    
4. Feeling discouraged about your 
diabetes regimen. 
 
    
5. Worrying about low blood sugar 
reactions. 
 
    
6.  Feeling constantly burned-out by 
the constant effort to manage 
diabetes. 
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7.  Not knowing if the mood or feelings 
you are experiencing are related to 
your blood glucose level. 
 
    
8.  Coping with the complications of 
diabetes. 
 
    
9.  Feeling that diabetes is taking up 
too much mental and physical energy. 
 
    
10.  Feeling constantly concerned 
about food. 
 
    
 
11.  Feeling depressed when you 
think about living with diabetes. 
 
    
12.  Feeling angry when you think 
about living with diabetes. 
 
    
13.  Feeling overwhelmed by your 
diabetes regimen. 
 
    
14.  Feeling alone with diabetes. 
     
15.  Feelings of deprivation regarding 
food and meals. 
 
    
16.  Not having clear and concrete 
goals for your diabetes care. 
 
    
17.  Uncomfortable interactions 
around diabetes with family/friends. 
 
    
18.  Not accepting diabetes. 
     
19.  Feeling that friends/family are not 
supportive of diabetes management 
efforts. 
 
    
20.  Feeling unsatisfied with your 
diabetes physician. 
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